ChromaDex Inc.

États‑Unis d’Amérique

Retour au propriétaire

1-87 de 87 pour ChromaDex Inc. Trier par
Recheche Texte
Affiner par
Type PI
        Marque 48
        Brevet 39
Juridiction
        États-Unis 54
        International 24
        Europe 5
        Canada 4
Date
Nouveautés (dernières 4 semaines) 2
2025 septembre 2
2025 août 1
2025 (AACJ) 5
2024 9
Voir plus
Classe IPC
C07H 19/048 - Radicaux pyridine 21
A61K 31/706 - Composés ayant des radicaux saccharide et des hétérocycles ayant l'azote comme hétéro-atome d'un cycle, p. ex. nucléosides, nucléotides contenant des cycles à six chaînons avec l'azote comme hétéro-atome d'un cycle 17
C07H 19/04 - Radicaux hétérocycliques contenant uniquement des atomes d'azote comme hétéro-atomes du cycle 12
C07D 307/20 - Atomes d'oxygène 8
C07H 19/20 - Radicaux purine avec le radical saccharide estérifié par des acides phosphoriques ou polyphosphoriques 7
Voir plus
Classe NICE
05 - Produits pharmaceutiques, vétérinaires et hygièniques 24
01 - Produits chimiques destinés à l'industrie, aux sciences ainsi qu'à l'agriculture 19
42 - Services scientifiques, technologiques et industriels, recherche et conception 10
41 - Éducation, divertissements, activités sportives et culturelles 9
35 - Publicité; Affaires commerciales 7
Voir plus
Statut
En Instance 23
Enregistré / En vigueur 64

1.

NIAGEN BIOSCIENCE

      
Numéro de série 99400130
Statut En instance
Date de dépôt 2025-09-18
Propriétaire CHROMADEX, INC. ()
Classes de Nice  ?
  • 41 - Éducation, divertissements, activités sportives et culturelles
  • 42 - Services scientifiques, technologiques et industriels, recherche et conception
  • 44 - Services médicaux, services vétérinaires, soins d'hygiène et de beauté; services d'agriculture, d'horticulture et de sylviculture.

Produits et services

Providing a website featuring blogs and non-downloadable publications in the nature of articles, newsletters, and blog posts in the field(s) of dietary supplements, nutritional supplements, pharmaceuticals, medicine, intravenous fluids, immunology, virology, cosmetics, non-medicated toiletry preparations, pet products, personal care products, food, beverages, fitness, exercise, workouts, wellness, lifestyle, health, nutrition, nicotinamide adenine dinucleotide, nicotinamide riboside chloride, cellular energy and repair, stress management, longevity, and healthy aging; Providing information on physical exercise; Education services, namely, providing training, seminars, and instruction in the field of dietary supplements, nutritional supplements, pharmaceuticals, medicine, intravenous fluids, immunology, virology, cosmetics, non-medicated toiletry preparations, pet products, personal care products, food, beverages, fitness, exercise, workouts, wellness, lifestyle, health, nutrition, nicotinamide adenine dinucleotide, nicotinamide riboside chloride, cellular energy and repair, stress management, longevity, and healthy aging Medical and scientific research information in the field of dietary supplements, nutritional supplements, pharmaceuticals, medicine, intravenous fluids, immunology, virology, cosmetics, non-medicated toiletry preparations, pet products, personal care products, food, beverages, fitness, exercise, workouts, wellness, lifestyle, health, nutrition, nicotinamide adenine dinucleotide, nicotinamide riboside chloride, cellular energy and repair, stress management, longevity, and healthy aging; Providing scientific research information in the field of dietary supplements, nutritional supplements, pharmaceuticals, medicine, intravenous fluids, immunology, virology, cosmetics, non-medicated toiletry preparations, pet products, personal care products, food, beverages, fitness, exercise, workouts, wellness, lifestyle, health, nutrition, nicotinamide adenine dinucleotide, nicotinamide riboside chloride, cellular energy and repair, stress management, longevity, and healthy aging; Providing medical and scientific research information in the field of clinical trials; Providing information in the field of clinical research via a website; Scientific research and development; Medical research; Product research and development; Providing scientific information in the field of dietary supplements, nutritional supplements, pharmaceuticals, medicine, intravenous fluids, immunology, virology, cosmetics, non-medicated toiletry preparations, pet products, personal care products, food, beverages, fitness, exercise, workouts, wellness, lifestyle, health, nutrition, nicotinamide adenine dinucleotide, nicotinamide riboside chloride, cellular energy and repair, stress management, longevity, and healthy aging; Innovation consulting services, namely, advising others in the areas of product development; Product development consulting in the field of dietary supplements, nutritional supplements, pharmaceuticals, medicine, intravenous fluids, immunology, virology, cosmetics, non-medicated toiletry preparations, pet products, personal care products, food, beverages, fitness, exercise, workouts, wellness, lifestyle, health, nutrition, nicotinamide adenine dinucleotide, nicotinamide riboside chloride, cellular energy and repair, stress management, longevity, and healthy aging; Scientific research consulting in the field of dietary supplements, nutritional supplements, pharmaceuticals, medicine, intravenous fluids, immunology, virology, cosmetics, non-medicated toiletry preparations, pet products, personal care products, food, beverages, fitness, exercise, workouts, wellness, lifestyle, health, nutrition, nicotinamide adenine dinucleotide, nicotinamide riboside chloride, cellular energy and repair, stress management, longevity, and healthy aging; Chemical, biochemical, biological and bacteriological research and analysis; Pharmaceutical research and development; Scientific and technological services, namely, testing, inspection, research, and development in the field of dietary supplements, nutritional supplements, pharmaceuticals, medicine, intravenous fluids, immunology, virology, cosmetics, cosmetic preparations, non-medicated toiletry preparations, pet products, personal care products, food, beverages, wellness, lifestyle, health, nutrition, nicotinamide adenine dinucleotide, nicotinamide riboside chloride, brain health, muscle health and recovery, immune health, heart health, cellular energy and repair, stress management, and healthy aging; Scientific research consulting; Research and development and consultation related thereto in the field of dietary supplements, nutritional supplements, pharmaceuticals, medicine, intravenous fluids, immunology, virology, cosmetics, non-medicated toiletry preparations, pet products, personal care products, food, beverages, fitness, exercise, workouts, wellness, lifestyle, health, nutrition, nicotinamide adenine dinucleotide, nicotinamide riboside chloride, cellular energy and repair, stress management, longevity, and healthy aging; Consulting services for others in the field of design, planning, and implementation project management of scientific research and clinical trials Providing information and advice in the field of pet health; Providing information in the fields of health and wellness; Providing information in the fields of health and wellness in the field of dietary supplements, nutritional supplements, pharmaceuticals, medicine, intravenous fluids, immunology, virology, cosmetics, non-medicated toiletry preparations, pet products, personal care products, food, beverages, fitness, exercise, workouts, lifestyle, nutrition, nicotinamide adenine dinucleotide, nicotinamide riboside chloride, cellular energy and repair, stress management, longevity, and healthy aging via a website; Providing information about dietary supplements and nutrition; Providing health information; Providing information about beauty; Providing beauty care information; Providing news and information in the field of personal beauty

2.

NIAGEN

      
Numéro d'application 1875662
Statut Enregistrée
Date de dépôt 2025-04-04
Date d'enregistrement 2025-04-04
Propriétaire CHROMADEX, INC. (USA)
Classes de Nice  ?
  • 01 - Produits chimiques destinés à l'industrie, aux sciences ainsi qu'à l'agriculture
  • 05 - Produits pharmaceutiques, vétérinaires et hygièniques

Produits et services

Active chemical ingredients for use in the manufacturing of dietary supplements, nutritional products, pharmaceuticals, cosmetics, cosmetic preparations, pet products, and personal care products; chemical reagents for non-medical purposes; chemicals for use in industry and science; chemicals for use in the biochemical and chemical industry; assays for research purposes; diagnostic preparations for scientific or research use; test kits comprised of chemical preparations and reagents for testing biomarkers and levels of nicotinamide adenine dinucleotide, vitamins, metabolites, and enzymes for scientific purposes, other than for medical or veterinary use; test kits comprised of chemical agents and chemical preparations for testing biomarkers and levels of nicotinamide adenine dinucleotide, vitamins, metabolites, and enzymes for scientific purposes, other than for medical or veterinary use; specimen collection kits comprised primarily of chemically treated non-medical test strips and cards and also including, laboratory swabs, plastic bags for transmitting specimens, printed mailing labels, and tubes for holding specimens for scientific purposes, other than for medical or veterinary use; test kits for testing for markers in bodily fluids, liquids, saliva and tissue for non-medical purposes; chemical preparations and articles, namely, chemical test paper, strips, and cards for the testing of nicotinamide adenine dinucleotide levels, cellular energy, brain health, muscle health and recovery, immune health, heart health, cellular energy and repair, stress management, and healthy aging for scientific purposes, other than for medical or veterinary use. Pharmaceutical preparations, namely, nicotinamide riboside chloride for injection; pharmaceutical preparations, namely, injectable liquids for use in hydration, vitamin, healthy aging, and wellness therapies; pharmaceutical preparations, namely, injectable liquids for increasing health, healthy aging, cellular health, cellular repair, energy, heart health, and muscle health; pharmaceutical preparations and nutritional supplements, namely, nicotinamide riboside chloride in the form of injectables; pharmaceutical preparations and nutritional supplements, namely, nicotinamide riboside chloride for use in intravenous therapy; diagnostic kits comprised of medical diagnostic assays for testing for biomarkers and levels of nicotinamide adenine dinucleotide, vitamins, metabolites, and enzymes for medical purposes; diagnostic kits for testing biomarkers and levels of nicotinamide adenine dinucleotide, vitamins, metabolites, and enzymes for medical purposes; diagnostic kits comprising diagnostic agents and preparations for medical purposes; specimen collection kits for medical purposes comprised primarily of swabs for medical purposes and also including test strips, plastic bags for transmitting medical specimens, printed mailing labels, and tubes for holding specimens; medical test kits comprised primarily of swabs, testing strips and cards for medical purposes, and also including lancets, adhesive bandages, plastic bags for transmitting medical specimens, and printed mailing labels for testing for markers in bodily fluids, liquids, saliva and tissue; diagnostic agents, preparations and substances for medical purposes; medical and veterinary diagnostic preparations and articles, namely, swabs, testing strips and cards for medical purposes for the testing of nicotinamide adenine dinucleotide levels, cellular energy, brain health, muscle health and recovery, immune health, heart health, cellular energy and repair, stress management, and healthy aging; diagnostic preparations and articles, namely, supplements, pharmaceutical preparations, and intravenous fluids for promoting nicotinamide adenine dinucleotide levels, cellular energy, brain health, muscle health and recovery, immune health, heart health, cellular energy and repair, stress management, and healthy aging for medical and veterinary use; prefilled syringes and medical fluid injectors sold filled with pharmaceutical preparations; prefilled syringes and injectors filled with pharmaceutical preparations, namely, nicotinamide adenine dinucleotide precursors for promoting nicotinamide adenine dinucleotide levels, cellular energy, brain health, muscle health and recovery, immune health, heart health, cellular energy and repair, stress management, and healthy aging; prefilled syringes and medical fluid injectors sold filled with nicotinamide riboside chloride; nutritional supplements in the form of an injection shot; pharmaceutical preparations and nutritional supplements, namely, nicotinamide riboside chloride in the form of an injection shot.

3.

NICOTINAMIDE RIBOSIDE AND DERIVATIVES THEREOF IN INTRAVENOUS FORMULATIONS AND METHODS OF USE THEREOF

      
Numéro d'application 19193361
Statut En instance
Date de dépôt 2025-04-29
Date de la première publication 2025-08-14
Propriétaire ChromaDex Inc. (USA)
Inventeur(s)
  • Erickson, Aron
  • Redpath, Philip
  • Nkrumah-Elie, Yasmeen Maisha
  • Shao, Andrew Earl

Abrégé

A stable intravenous (I.V.) composition includes nicotinamide riboside (NR) as described, or other nicotinyl riboside compounds which are NAD+ precursors, in said intravenous form. NR chloride may be provided in an intravenous (I.V.) formulation for administration to a human subject.

Classes IPC  ?

  • A61K 31/706 - Composés ayant des radicaux saccharide et des hétérocycles ayant l'azote comme hétéro-atome d'un cycle, p. ex. nucléosides, nucléotides contenant des cycles à six chaînons avec l'azote comme hétéro-atome d'un cycle
  • A61K 9/00 - Préparations médicinales caractérisées par un aspect particulier
  • A61K 31/7084 - Composés ayant deux nucléosides ou nucléotides, p. ex. dinucléotide de la nicotinamide-adénine, dinucléotide de la flavine-adénine

4.

EFFICIENT AND SCALABLE SYNTHESES OF NICOTINOYL RIBOSIDES AND REDUCED NICOTINOYL RIBOSIDES, MODIFIED DERIVATIVES THEREOF, PHOSPHORYLATED ANALOGS THEREOF, ADENYLYL DINUCLEOTIDE CONJUGATES THEREOF, AND NOVEL CRYSTALLINE FORMS THEREOF

      
Numéro d'application 19015302
Statut En instance
Date de dépôt 2025-01-09
Date de la première publication 2025-05-22
Propriétaire
  • The Queen's University of Belfast (Royaume‑Uni)
  • ChromaDex Inc. (USA)
Inventeur(s)
  • Migaud, Marie Eugenie
  • Redpath, Philip
  • Crossey, Kerri
  • Cunningham, Richard
  • Erickson, Aron
  • Nygaard, Richard
  • Storjohann, Amanda

Abrégé

The present disclosure provides methods of making nicotinoyl riboside compounds or derivatives of formula (I): The present disclosure provides methods of making nicotinoyl riboside compounds or derivatives of formula (I): The present disclosure provides methods of making nicotinoyl riboside compounds or derivatives of formula (I): wherein X−, Z1, Z2, n, R1, R2, R3, R4, R5, R6, R7, and R8 are described herein, reduced analogs thereof, modified derivatives thereof, phosphorylated analogs thereof, and adenylyl dinucleotide conjugates thereof, or salts, solvates, or prodrugs thereof, and novel crystalline forms thereof.

Classes IPC  ?

  • C07H 19/048 - Radicaux pyridine
  • C07D 307/20 - Atomes d'oxygène
  • C07H 19/04 - Radicaux hétérocycliques contenant uniquement des atomes d'azote comme hétéro-atomes du cycle
  • C07H 19/20 - Radicaux purine avec le radical saccharide estérifié par des acides phosphoriques ou polyphosphoriques

5.

NIAGEN

      
Numéro de série 99120020
Statut En instance
Date de dépôt 2025-04-03
Propriétaire CHROMADEX, INC. ()
Classes de Nice  ? 05 - Produits pharmaceutiques, vétérinaires et hygièniques

Produits et services

Dietary supplements; Nutritional supplements; Dietary supplements for health, cellular energy, cellular health, cellular repair, brain health, muscle health and recovery, immune health, heart health, stress management, and healthy aging; Nutritional supplements for health, cellular energy, cellular health, cellular repair, brain health, muscle health and recovery, immune health, heart health, stress management, and healthy aging

6.

NICOTINAMIDE RIBOSIDE AND DERIVATIVES THEREOF IN INTRAVENOUS FORMULATIONS AND METHODS OF USE THEREOF

      
Numéro d'application 18744419
Statut En instance
Date de dépôt 2024-06-14
Date de la première publication 2024-12-19
Propriétaire ChromaDex Inc. (USA)
Inventeur(s)
  • Erickson, Aron
  • Redpath, Philip
  • Nkrumah-Elie, Yasmeen Maisha
  • Shao, Andrew Earl

Abrégé

A stable intravenous (I.V.) composition includes nicotinamide riboside (NR) as described, or other nicotinyl riboside compounds which are NAD+ precursors, in said intravenous form. NR chloride may be provided in an intravenous (I.V.) formulation for administration to a human subject.

Classes IPC  ?

  • A61K 31/706 - Composés ayant des radicaux saccharide et des hétérocycles ayant l'azote comme hétéro-atome d'un cycle, p. ex. nucléosides, nucléotides contenant des cycles à six chaînons avec l'azote comme hétéro-atome d'un cycle
  • A61K 9/00 - Préparations médicinales caractérisées par un aspect particulier
  • A61K 31/7084 - Composés ayant deux nucléosides ou nucléotides, p. ex. dinucléotide de la nicotinamide-adénine, dinucléotide de la flavine-adénine

7.

NICOTINAMIDE RIBOSIDE AND DERIVATIVES THEREOF IN INTRAVENOUS FORMULATIONS AND METHODS OF USE THEREOF

      
Numéro d'application US2024034183
Numéro de publication 2024/259359
Statut Délivré - en vigueur
Date de dépôt 2024-06-14
Date de publication 2024-12-19
Propriétaire CHROMADEX INC. (USA)
Inventeur(s)
  • Erickson, Aron
  • Redpath, Philip
  • Nkrumah-Elie, Yasmeen Maisha
  • Shao, Andrew Earl

Abrégé

A stable intravenous (I.V.) composition includes nicotinamide riboside (NR) as described, or other nicotinyl riboside compounds which are NAD+ precursors, in said intravenous form. NR chloride may be provided in an intravenous (I.V.) formulation for administration to a human subject.

Classes IPC  ?

  • A61K 31/395 - Composés hétérocycliques ayant l'azote comme hétéro-atome d'un cycle, p. ex. guanéthidine ou rifamycines
  • A61K 31/7052 - Composés ayant des radicaux saccharide et des hétérocycles ayant l'azote comme hétéro-atome d'un cycle, p. ex. nucléosides, nucléotides
  • A61K 9/00 - Préparations médicinales caractérisées par un aspect particulier

8.

NIAGEN

      
Numéro de série 98788240
Statut En instance
Date de dépôt 2024-10-07
Propriétaire CHROMADEX, INC. ()
Classes de Nice  ?
  • 01 - Produits chimiques destinés à l'industrie, aux sciences ainsi qu'à l'agriculture
  • 05 - Produits pharmaceutiques, vétérinaires et hygièniques

Produits et services

Active Chemical ingredients for use in the manufacturing of dietary supplements, nutritional products, pharmaceuticals, cosmetics, cosmetic preparations, pet products, and personal care products; chemical reagents for non-medical purposes; chemicals for use in industry and science; chemicals for use in the biochemical and chemical industry; assays for research purposes; diagnostic preparations for scientific or research use; test kits comprised of chemical preparations and reagents for testing biomarkers and levels of nicotinamide adenine dinucleotide, vitamins, metabolites, and enzymes for scientific purposes, other than for medical or veterinary use; test kits comprised of chemical agents and chemical preparations for testing biomarkers and levels of nicotinamide adenine dinucleotide, vitamins, metabolites, and enzymes for scientific purposes, other than for medical or veterinary use; specimen collection kits comprised primarily of chemically treated non-medical test strips and cards and also including, laboratory swabs, plastic bags for transmitting specimens, printed mailing labels, and tubes for holding specimens for scientific purposes, other than for medical or veterinary use; test kits for testing for markers in bodily fluids, liquids, saliva and tissue for non-medical purposes; chemical preparations and articles, namely, chemical test paper, strips, and cards for the testing of nicotinamide adenine dinucleotide levels, cellular energy, brain health, muscle health and recovery, immune health, heart health, cellular energy and repair, stress management, and healthy aging for scientific purposes, other than for medical or veterinary use Pharmaceutical preparations, namely, nicotinamide riboside chloride for injection; pharmaceutical preparations, namely, injectable liquids for use in hydration, vitamin, healthy aging, and wellness therapies; pharmaceutical preparations, namely, injectable liquids for increasing health, healthy aging, cellular health, cellular repair, energy, heart health, and muscle health; pharmaceutical preparations and nutritional supplements, namely, nicotinamide riboside chloride in the form of injectables; pharmaceutical preparations and nutritional supplements, namely, nicotinamide riboside chloride for use in intravenous therapy; diagnostic kits comprised of medical diagnostic assays for testing for biomarkers and levels of nicotinamide adenine dinucleotide, vitamins, metabolites, and enzymes for medical purposes; diagnostic kits for testing biomarkers and levels of nicotinamide adenine dinucleotide, vitamins, metabolites, and enzymes for medical purposes; diagnostic kits comprising diagnostic agents and preparations for medical purposes; specimen collection kits for medical purposes comprised primarily of swabs for medical purposes and also including test strips, plastic bags for transmitting medical specimens, printed mailing labels, and tubes for holding specimens; medical test kits comprised primarily of swabs, testing strips and cards for medical purposes, and also including lancets, adhesive bandages, plastic bags for transmitting medical specimens, and printed mailing labels for testing for markers in bodily fluids, liquids, saliva and tissue; diagnostic agents, preparations and substances for medical purposes; medical and veterinary diagnostic preparations and articles, namely, swabs, testing strips and cards for medical purposes for the testing of nicotinamide adenine dinucleotide levels, cellular energy, brain health, muscle health and recovery, immune health, heart health, cellular energy and repair, stress management, and healthy aging; diagnostic preparations and articles, namely, supplements, pharmaceutical preparations, and intravenous fluids for promoting nicotinamide adenine dinucleotide levels, cellular energy, brain health, muscle health and recovery, immune health, heart health, cellular energy and repair, stress management, and healthy aging for medical and veterinary use; prefilled syringes and medical fluid injectors sold filled with pharmaceutical preparations; prefilled syringes and injectors filled with pharmaceutical preparations, namely, nicotinamide adenine dinucleotide precursors for promoting nicotinamide adenine dinucleotide levels, cellular energy, brain health, muscle health and recovery, immune health, heart health, cellular energy and repair, stress management, and healthy aging; prefilled syringes and medical fluid injectors sold filled with nicotinamide riboside chloride; nutritional supplements in the form of an injection shot; pharmaceutical preparations and nutritional supplements, namely, nicotinamide riboside chloride in the form of an injection shot

9.

TRU NIAGEN

      
Numéro de série 98666266
Statut En instance
Date de dépôt 2024-07-25
Propriétaire CHROMADEX, INC. ()
Classes de Nice  ? 35 - Publicité; Affaires commerciales

Produits et services

On-line retail store services featuring dietary supplements, nutritional supplements, cosmetics, cosmetic preparations, non-medicated toiletry preparations, pet products, personal care products, food, and beverages; Retail store services featuring dietary supplements, nutritional supplements, cosmetics, cosmetic preparations, non-medicated toiletry preparations, pet products, personal care products, food, and beverages

10.

TRU NIAGEN

      
Numéro de série 98663151
Statut En instance
Date de dépôt 2024-07-23
Propriétaire CHROMADEX, INC. ()
Classes de Nice  ? 03 - Produits cosmétiques et préparations de toilette; préparations pour blanchir, nettoyer, polir et abraser.

Produits et services

Cosmetics; cosmetic preparations; non-medicated toiletry preparations; chemicals sold as components of cosmetics and cosmetic preparations; nutritional supplements sold as a component of cosmetics and cosmetic preparations; body and beauty care cosmetics; cosmetic preparations for body care; cosmetic preparations for skin care; cosmetic preparations in the form of scrubs, lotions, oils, serums, toners, moisturizers, creams, gels, powders, aerosols, sprays, emulsions, pomades, and masks; cosmetic suntan preparations; non-medicated soaps; cosmetic preparations for bath and shower; hair care preparations; cosmetics for animals; make-up; make-up preparations; perfume; cologne; nail care preparations; nail polish

11.

NIAGEN NANOCLOUD

      
Numéro de série 98644474
Statut En instance
Date de dépôt 2024-07-11
Propriétaire CHROMADEX, INC. ()
Classes de Nice  ? 03 - Produits cosmétiques et préparations de toilette; préparations pour blanchir, nettoyer, polir et abraser.

Produits et services

Cosmetics; cosmetic preparations; non-medicated toiletry preparations; chemicals sold as components of cosmetics and cosmetic preparations; nutritional supplements sold as a component of cosmetics and cosmetic preparations; body and beauty care cosmetics; cosmetic preparations for body care; cosmetic preparations for skin care; cosmetic preparations in the form of scrubs, lotions, oils, serums, toners, moisturizers, creams, gels, powders, aerosols, sprays, emulsions, pomades, and masks; non-medicated soaps; cosmetic preparations for bath and shower; hair care preparations; cosmetics for animals

12.

NANOCLOUD

      
Numéro de série 98644492
Statut En instance
Date de dépôt 2024-07-11
Propriétaire CHROMADEX, INC. ()
Classes de Nice  ? 03 - Produits cosmétiques et préparations de toilette; préparations pour blanchir, nettoyer, polir et abraser.

Produits et services

Cosmetics; cosmetic preparations; non-medicated toiletry preparations; chemicals sold as components of cosmetics and cosmetic preparations; nutritional supplements sold as a component of cosmetics and cosmetic preparations; body and beauty care cosmetics; cosmetic preparations for body care; cosmetic preparations for skin care; cosmetic preparations in the form of scrubs, lotions, oils, serums, toners, moisturizers, creams, gels, powders, aerosols, sprays, emulsions, pomades, and masks; non-medicated soaps; cosmetic preparations for bath and shower; hair care preparations; cosmetics for animals

13.

NIAGEN

      
Numéro d'application 232305200
Statut En instance
Date de dépôt 2024-04-23
Propriétaire ChromaDex, Inc. (USA)
Classes de Nice  ? 03 - Produits cosmétiques et préparations de toilette; préparations pour blanchir, nettoyer, polir et abraser.

Produits et services

(1) Body and beauty care cosmetics; body emulsions for cosmetic purposes; body sprays for cosmetic purposes; cosmetic bath and shower gels; cosmetic body scrubs; cosmetic facial care preparations; cosmetic hair care preparations; cosmetic masks; cosmetic moisturizing skin gels; cosmetic nail care preparations; cosmetic oils; cosmetic powders, creams and lotions for the face, hands and body; cosmetic preparations for skin care; cosmetic serums for firming the skin; cosmetic soaps; cosmetic suntan preparations; cosmetics; facial serums for cosmetic purposes; hair care preparations; make-up; make-up preparations; pomades for cosmetic purposes; skin moisturizers used as cosmetics; toners for cosmetic use;

14.

NIAGEN

      
Numéro de série 98482923
Statut En instance
Date de dépôt 2024-04-03
Propriétaire CHROMADEX, INC. ()
Classes de Nice  ? 03 - Produits cosmétiques et préparations de toilette; préparations pour blanchir, nettoyer, polir et abraser.

Produits et services

Cosmetics; cosmetic preparations; non-medicated toiletry preparations; chemicals sold as components of cosmetics and cosmetic preparations; nutritional supplements sold as a component of cosmetics and cosmetic preparations; body and beauty care cosmetics; cosmetic preparations for body care; cosmetic preparations for skin care; cosmetic preparations in the form of scrubs, lotions, oils, serums, toners, moisturizers, creams, gels, powders, aerosols, sprays, emulsions, pomades, and masks; cosmetic suntan preparations; cosmetic soaps; cosmetic preparations for bath and shower; hair care preparations; cosmetics for animals; make-up; make-up preparations; perfume; cologne; nail care preparations; nail polish

15.

Efficient and scalable syntheses of nicotinoyl ribosides and reduced nicotinoyl ribosides, modified derivatives thereof, phosphorylated analogs thereof, adenylyl dinucleotide conjugates thereof, and novel crystalline forms thereof

      
Numéro d'application 18237503
Numéro de brevet 12195494
Statut Délivré - en vigueur
Date de dépôt 2023-08-24
Date de la première publication 2023-12-07
Date d'octroi 2025-01-14
Propriétaire
  • The Queen's University of Belfast (Royaume‑Uni)
  • ChromaDex Inc. (USA)
Inventeur(s)
  • Migaud, Marie Eugenie
  • Redpath, Philip
  • Crossey, Kerri
  • Cunningham, Richard
  • Erickson, Aron
  • Nygaard, Richard
  • Storjohann, Amanda

Abrégé

The present disclosure provides methods of making nicotinoyl riboside compounds or derivatives of formula (I): 8 are described herein, reduced analogs thereof, modified derivatives thereof, phosphorylated analogs thereof, and adenylyl dinucleotide conjugates thereof, or salts, solvates, or prodrugs thereof, and novel crystalline forms thereof.

Classes IPC  ?

  • C07H 19/048 - Radicaux pyridine
  • C07D 307/20 - Atomes d'oxygène
  • C07H 19/20 - Radicaux purine avec le radical saccharide estérifié par des acides phosphoriques ou polyphosphoriques
  • C07H 19/04 - Radicaux hétérocycliques contenant uniquement des atomes d'azote comme hétéro-atomes du cycle

16.

NRIV

      
Numéro de série 98272144
Statut En instance
Date de dépôt 2023-11-15
Propriétaire Chromadex, Inc. ()
Classes de Nice  ?
  • 05 - Produits pharmaceutiques, vétérinaires et hygièniques
  • 35 - Publicité; Affaires commerciales
  • 44 - Services médicaux, services vétérinaires, soins d'hygiène et de beauté; services d'agriculture, d'horticulture et de sylviculture.

Produits et services

Pharmaceutical preparations, namely, nicotinamide riboside for injection; pharmaceutical preparations, namely, injectable liquids for use in hydration, vitamin, healthy aging, and wellness therapies; pharmaceutical preparations, namely, injectable liquids for increasing health, healthy aging, cellular health, cellular repair, energy, heart health, and muscle health; nicotinamide riboside in the form of injectables; nicotinamide riboside for use in intravenous therapy; dietary supplements; nutritional supplements On-line retail store services featuring injectable intravenous solutions, dietary supplements, and nutritional supplements; retail store services featuring injectable intravenous solutions, dietary supplements, and nutritional supplements Intravenous therapy services; intravenous therapy services featuring nicotinamide riboside; providing information about health, healthy aging, lifestyle wellness, healthy eating, and nutrition

17.

METHODS OF PRODUCING CRYSTALLINE BETA NICOTINAMIDE RIBOSIDE TRIACETATE CHLORIDE

      
Numéro d'application US2023015301
Numéro de publication 2023/177743
Statut Délivré - en vigueur
Date de dépôt 2023-03-15
Date de publication 2023-09-21
Propriétaire CHROMADEX INC. (USA)
Inventeur(s)
  • Erickson, Aron
  • Redpath, Philip
  • Roodman, Jacob
  • Nygaard, Richard

Abrégé

This disclosure relates to a process for producing Crystalline Beta Nicotinamide Riboside Triacetate Chloride with improved physical property characteristics. A substantially crystalline Beta Nicotinamide Riboside Triacetate Chloride, or a salt, or a solvate thereof is described having a chemical purity of greater than about 90% (w/w) and containing less than about 5000 ppm ethanol.

Classes IPC  ?

  • C07H 19/048 - Radicaux pyridine
  • A61K 31/706 - Composés ayant des radicaux saccharide et des hétérocycles ayant l'azote comme hétéro-atome d'un cycle, p. ex. nucléosides, nucléotides contenant des cycles à six chaînons avec l'azote comme hétéro-atome d'un cycle
  • C07H 1/00 - Procédés de préparation des dérivés du sucre

18.

METHODS OF PRODUCING CRYSTALLINE BETA NICOTINAMIDE RIBOSIDE TRIACETATE CHLORIDE

      
Numéro d'application 18184456
Statut En instance
Date de dépôt 2023-03-15
Date de la première publication 2023-09-21
Propriétaire ChromaDex Inc. (USA)
Inventeur(s)
  • Erickson, Aron
  • Redpath, Philip
  • Roodman, Jacob
  • Nygaard, Richard

Abrégé

This disclosure relates to a process for producing Crystalline Beta Nicotinamide Riboside Triacetate Chloride with improved physical property characteristics. A substantially crystalline Beta Nicotinamide Riboside Triacetate Chloride, or a salt, or a solvate thereof is described having a chemical purity of greater than about 90% (w/w) and containing less than about 5000 ppm ethanol.

Classes IPC  ?

19.

TRU NAD+

      
Numéro de série 98084355
Statut En instance
Date de dépôt 2023-07-13
Propriétaire Chromadex, Inc. ()
Classes de Nice  ?
  • 01 - Produits chimiques destinés à l'industrie, aux sciences ainsi qu'à l'agriculture
  • 03 - Produits cosmétiques et préparations de toilette; préparations pour blanchir, nettoyer, polir et abraser.
  • 05 - Produits pharmaceutiques, vétérinaires et hygièniques
  • 35 - Publicité; Affaires commerciales
  • 41 - Éducation, divertissements, activités sportives et culturelles
  • 42 - Services scientifiques, technologiques et industriels, recherche et conception
  • 44 - Services médicaux, services vétérinaires, soins d'hygiène et de beauté; services d'agriculture, d'horticulture et de sylviculture.

Produits et services

Active chemical ingredients for use in the manufacturing of dietary supplements, nutritional products, pharmaceuticals, cosmetics, cosmetic preparations, pet products, and personal care products; Chemical reagents for non-medical purposes; Chemicals for use in industry and science; Chemicals for use in the biochemical and chemical industry; Assays for research purposes; Diagnostic preparations for scientific or research use Cosmetics; cosmetic preparations; non-medicated toiletry preparations; chemicals sold as components of cosmetics and cosmetic preparations; nutritional supplements sold as a component of cosmetics and cosmetic preparations; cosmetic preparations; body and beauty care cosmetics; cosmetic preparations for body care; cosmetic preparations for skin care; cosmetic preparations in the form of scrubs, lotions, oils, serums, toners, moisturizers, creams, gels, powders, aerosols, sprays, emulsions, pomades, and masks; cosmetic suntan preparations; cosmetic soaps; cosmetic preparations for bath and shower; hair care preparations; cosmetics for animals; make-up; make-up preparations; perfume; cologne; nail care preparations; nail polish Dietary and nutritional supplements; diagnostic kits consisting primarily of monoclonal antibodies, buffers, and reagents for use in disease testing; diagnostic preparations for medical purposes; diagnostic agents, preparations and substances for medical purposes; dietary supplements and preparations; medical and veterinary preparations and articles for the treatment of declining nicotinamide adenine dinucleotide levels and cellular energy, and for the support of brain health, muscle health and recovery, immune health, heart health, cellular energy and repair, stress management, and healthy aging On-line retail store services featuring dietary supplements, nutritional supplements, cosmetics, cosmetic preparations, pet products, personal care products, food, and beverages; Retail store services featuring dietary supplements, nutritional supplements, cosmetics, cosmetic preparations, pet products, personal care products, food, and beverages Providing a website and non-downloadable publications in the nature of articles, newsletters, and blog posts in the field of health, fitness, exercise, workouts, wellness, lifestyle, cosmetics, pet products, personal care products, healthy eating, dietary and nutritional supplements, and nutrition; Providing information and reviews about physical fitness, exercise and fitness workouts Medical and scientific research information in the field of health, nutrition, dietary and nutritional supplements, cosmetics, pet products, personal care products, cellular energy, nicotinamide adenine dinucleotide, and nicotinamide riboside; Providing scientific information in the field of research regarding health, nutrition, dietary and nutritional supplements, cosmetics, pet products, personal care products, cellular energy, nicotinamide adenine dinucleotide, and nicotinamide riboside; Providing scientific research information in the field of clinical studies; Providing a website featuring educational information in the field of clinical research Providing information about health, lifestyle, wellness, cosmetics, personal care products, pet health and wellness products, healthy eating, dietary and nutritional supplements, and nutrition

20.

USE OF NICOTINAMIDE RIBOSIDE, NICOTINIC ACID RIBOSIDE, AND NICOTINAMIDE MONONUCLEOTIDE, REDUCED NICOTINYL COMPOUNDS, AND NICOTINOYL COMPOUND DERIVATIVES IN INFANT FORMULA FOR HEALTHY DEVELOPMENT

      
Numéro d'application 18060257
Statut En instance
Date de dépôt 2022-11-30
Date de la première publication 2023-06-29
Propriétaire ChromaDex Inc. (USA)
Inventeur(s)
  • Dellinger, Ryan
  • Rhonemus, Troy
  • Morris, Mark
  • Conze, Dietrich
  • Boileau, Amy

Abrégé

Infant formula compositions and methods for delivering at least one compound selected from nicotinamide riboside (NR), nicotinic acid riboside (NAR), and nicotinamide mononucleotide (NMN), derivatives thereof, or salts thereof, in combination with at least one of thiamine (vitamin B1), riboflavin (vitamin B2), niacin (vitamin B3), and pyridoxine (vitamin B6), to an infant human subject in need of said compound or compounds are provided.

Classes IPC  ?

  • A61K 31/706 - Composés ayant des radicaux saccharide et des hétérocycles ayant l'azote comme hétéro-atome d'un cycle, p. ex. nucléosides, nucléotides contenant des cycles à six chaînons avec l'azote comme hétéro-atome d'un cycle
  • A61K 31/51 - Thiamines, p. ex. vitamine B1
  • A23L 33/10 - Modification de la qualité nutritive des alimentsProduits diététiquesLeur préparation ou leur traitement en utilisant des additifs
  • A61K 31/4415 - Pyridoxine, c.-à-d. vitamine B6
  • A61K 31/455 - Acide nicotinique, c.-à-d. niacineSes dérivés, p. ex. esters, amides
  • A61K 31/525 - Iso-alloxazines, p. ex. riboflavines, vitamine B2
  • A61K 31/7064 - Composés ayant des radicaux saccharide et des hétérocycles ayant l'azote comme hétéro-atome d'un cycle, p. ex. nucléosides, nucléotides contenant des cycles à six chaînons avec l'azote comme hétéro-atome d'un cycle contenant des pyrimidines condensées ou non-condensées
  • A23L 33/19 - Protéines du lait
  • A23L 33/00 - Modification de la qualité nutritive des alimentsProduits diététiquesLeur préparation ou leur traitement
  • A23L 33/15 - Vitamines
  • A61K 45/06 - Mélanges d'ingrédients actifs sans caractérisation chimique, p. ex. composés antiphlogistiques et pour le cœur
  • A61K 47/42 - ProtéinesPolypeptidesLeurs produits de dégradationLeurs dérivés p. ex. albumine, gélatine ou zéine

21.

CERP

      
Numéro d'application 018883916
Statut En instance
Date de dépôt 2023-06-05
Propriétaire ChromaDex, Inc. (USA)
Classes de Nice  ? 42 - Services scientifiques, technologiques et industriels, recherche et conception

Produits et services

Innovation consulting services, namely, advising others in the areas of product development; Product development consulting in the field of dietary supplements, nutritional products, pharmaceuticals, health, medicine, aging, immunology, virology, and cosmetics; Scientific research consulting in the field of dietary supplements, nutritional products, pharmaceuticals, health, medicine, aging, immunology, virology, and cosmetics; Scientific consulting and research services relating to foods and dietary supplements; Chemical, biochemical, biological and bacteriological research and analysis; Industrial research in the field of chemicals; Pharmaceutical research and development; Testing, inspection, research, or development of dietary supplements, nutritional products, pharmaceuticals, medicine, and cosmetics; Product research and development; Scientific research and development; Scientific research consulting; Medical research; Research and development and consultation related thereto in the field of dietary supplements, nutritional products, pharmaceuticals, health, medicine, aging, immunology, virology, cosmetics, chemicals, chemical standards, and chemical reference materials; Consulting services for others in the field of design, planning, and implementation project management of scientific research and clinical trials; Design and testing for new product development; Testing, inspection or research of pharmaceuticals, cosmetics or foodstuff.

22.

Niagen

      
Numéro d'application 018850193
Statut Enregistrée
Date de dépôt 2023-03-17
Date d'enregistrement 2023-04-12
Propriétaire ChromaDex, Inc. (USA)
Classes de Nice  ?
  • 05 - Produits pharmaceutiques, vétérinaires et hygièniques
  • 09 - Appareils et instruments scientifiques et électriques
  • 41 - Éducation, divertissements, activités sportives et culturelles

Produits et services

Diagnostic kits consisting primarily of monoclonal antibodies, buffers, and reagents for use in disease testing; diagnostic preparations for medical purposes; diagnostic agents, preparations and substances for medical purposes; dietary preparations; medical and veterinary preparations and articles. Downloadable mobile applications for managing and sharing information on one's health, fitness and nutrition; downloadable software in the nature of a mobile application for providing information in the fields of health, fitness, exercise, workouts, wellness, lifestyle, healthy eating and nutrition; downloadable mobile application software for the purpose of tracking and monitoring health, wellness and nutrition; computer software for providing information in the fields of health, fitness, exercise, workouts, wellness, lifestyle, healthy eating and nutrition. Providing information about fitness, exercise, and workouts; on-line journals, namely, blogs featuring articles, information, reviews and recipes in the field of health, fitness, exercise, workouts, wellness, lifestyle, healthy eating and nutrition.

23.

CERP

      
Numéro de série 97778081
Statut Enregistrée
Date de dépôt 2023-02-02
Date d'enregistrement 2024-02-20
Propriétaire Chromadex, Inc. ()
Classes de Nice  ? 42 - Services scientifiques, technologiques et industriels, recherche et conception

Produits et services

Innovation consulting services, namely, advising others in the areas of product development; Product development consulting in the field of dietary supplements, nutritional products, pharmaceuticals, health, medicine, aging, immunology, virology, and cosmetics; Scientific research consulting in the field of dietary supplements, nutritional products, pharmaceuticals, health, medicine, aging, immunology, virology, and cosmetics; Scientific consulting and research services relating to foods and dietary supplements; Chemical, biochemical, biological and bacteriological research and analysis; Industrial research in the field of chemicals; Pharmaceutical research and development; Testing, inspection, research, or development of dietary supplements, nutritional products, pharmaceuticals, medicine, and cosmetics; Product research and development; Scientific research and development; Scientific research consulting; Medical research; Research and development and consultation related thereto in the field of dietary supplements, nutritional products, pharmaceuticals, health, medicine, aging, immunology, virology, cosmetics, chemicals, chemical standards, and chemical reference materials; Consulting services for others in the field of design, planning, and implementation project management of scientific research and clinical trials; Design and testing for new product development; Testing, inspection or research of pharmaceuticals, cosmetics or foodstuff

24.

CHROMADEX STANDARDS

      
Numéro d'application 018786405
Statut Enregistrée
Date de dépôt 2022-10-28
Date d'enregistrement 2023-03-07
Propriétaire ChromaDex, Inc. (USA)
Classes de Nice  ? 01 - Produits chimiques destinés à l'industrie, aux sciences ainsi qu'à l'agriculture

Produits et services

Standards and reference materials to be used in the calibration of laboratory measuring instruments and used in laboratory research and analysis; Standards and reference materials to be used in the calibration of laboratory measuring instruments and used in laboratory research and analysis, namely, certified samples of botanical materials, chemical solids, and liquids in the nature of reagents and synthetic and natural oxides in the form of powders, liquids, pastes and granules.

25.

CHROMADEX STANDARDS

      
Numéro de série 97645874
Statut Enregistrée
Date de dépôt 2022-10-24
Date d'enregistrement 2023-05-02
Propriétaire Chromadex, Inc. ()
Classes de Nice  ? 01 - Produits chimiques destinés à l'industrie, aux sciences ainsi qu'à l'agriculture

Produits et services

Standards and reference materials to be used in the calibration of laboratory measuring instruments and used in laboratory research and analysis, namely, chemical standards and reference materials, other than for medical or veterinary purposes; Standards and reference materials to be used in the calibration of laboratory measuring instruments and used in laboratory research and analysis, namely, certified samples of botanical extracts and chemical solids, and liquids in the nature of reagents for laboratory research and analysis, and synthetic and natural oxides in the form of powders, liquids, pastes and granules for laboratory research and analysis other than for medical or veterinary purposes

26.

ETHYL CELLULOSE BASED COATINGS FOR MICROENCAPSULATION OF NICOTINAMIDE RIBOSIDE, NICOTINIC ACID RIBOSIDE, REDUCED NICOTINYL RIBOSIDE COMPOUNDS, AND NICOTINYL RIBOSIDE COMPOUND DERIVATIVES

      
Numéro d'application 17589422
Statut En instance
Date de dépôt 2022-01-31
Date de la première publication 2022-08-04
Propriétaire CHROMADEX INC. (USA)
Inventeur(s)
  • Erickson, Aron
  • Storjohann, Amanda
  • Holloway, Joshua
  • Redpath, Philip

Abrégé

A process is provided for microencapsulating nicotinamide riboside (NR), and other NR derivatives by using ethyl cellulose which may be polymerized in a particular manner. Further, compositions comprising NR or derivatives thereof microencapsulated in an edible biopolymer are provided.

Classes IPC  ?

  • A61K 31/706 - Composés ayant des radicaux saccharide et des hétérocycles ayant l'azote comme hétéro-atome d'un cycle, p. ex. nucléosides, nucléotides contenant des cycles à six chaînons avec l'azote comme hétéro-atome d'un cycle
  • A61K 9/50 - Microcapsules

27.

ETHYL CELLULOSE BASED COATINGS FOR MICROENCAPSULATION OF NICOTINAMIDE RIBOSIDE AND OTHER NICOTINYL RIBOSIDE COMPOUNDS

      
Numéro d'application US2022014597
Numéro de publication 2022/165358
Statut Délivré - en vigueur
Date de dépôt 2022-01-31
Date de publication 2022-08-04
Propriétaire CHROMADEX INC. (USA)
Inventeur(s)
  • Erickson, Aron
  • Storjohann, Amanda
  • Holloway, Joshua
  • Redpath, Philip

Abrégé

A process is provided for microencapsulating nicotinamide riboside (NR), and other NR derivatives by using ethyl cellulose which may be polymerized in a particular manner. Further, compositions comprising NR or derivatives thereof microencapsulated in an edible biopolymer are provided.

Classes IPC  ?

  • A61K 31/706 - Composés ayant des radicaux saccharide et des hétérocycles ayant l'azote comme hétéro-atome d'un cycle, p. ex. nucléosides, nucléotides contenant des cycles à six chaînons avec l'azote comme hétéro-atome d'un cycle
  • A61K 47/38 - CelluloseSes dérivés
  • A61K 9/50 - Microcapsules
  • A61K 8/11 - Compositions encapsulées
  • C07H 19/048 - Radicaux pyridine

28.

Efficient and scalable syntheses of nicotinoyl ribosides and reduced nicotinoyl ribosides, modified derivatives thereof, phosphorylated analogs thereof, adenylyl dinucleotide conjugates thereof, and novel crystalline forms thereof

      
Numéro d'application 17551592
Numéro de brevet 11345720
Statut Délivré - en vigueur
Date de dépôt 2021-12-15
Date de la première publication 2022-04-07
Date d'octroi 2022-05-31
Propriétaire
  • The Queen's University of Belfast (Royaume‑Uni)
  • ChromaDex Inc. (USA)
Inventeur(s)
  • Migaud, Marie Eugenie
  • Redpath, Philip
  • Crossey, Kerri
  • Cunningham, Richard
  • Erickson, Aron
  • Nygaard, Richard
  • Storjohann, Amanda

Abrégé

The present disclosure provides methods of making nicotinoyl riboside compounds or derivatives of formula (I): 8 are described herein, reduced analogs thereof, modified derivatives thereof, phosphorylated analogs thereof, and adenylyl dinucleotide conjugates thereof, or salts, solvates, or prodrugs thereof; and novel crystalline forms thereof.

Classes IPC  ?

  • C07H 19/207 - Radicaux purine avec le radical saccharide estérifié par des acides phosphoriques ou polyphosphoriques les acides phosphoriques ou polyphosphoriques étant estérifiés par un autre composé hydroxylique, p. ex. les dinucléotides de la flavine-adénine ou de la nicotinamide-adénine
  • C07H 19/048 - Radicaux pyridine
  • C07D 307/20 - Atomes d'oxygène
  • C07H 19/20 - Radicaux purine avec le radical saccharide estérifié par des acides phosphoriques ou polyphosphoriques
  • C07H 19/04 - Radicaux hétérocycliques contenant uniquement des atomes d'azote comme hétéro-atomes du cycle

29.

Efficient and scalable syntheses of nicotinoyl ribosides and reduced nicotinoyl ribosides, modified derivatives thereof, phosphorylated analogs thereof, adenylyl dinucleotide conjugates thereof, and novel crystalline forms thereof

      
Numéro d'application 17323789
Numéro de brevet 11242364
Statut Délivré - en vigueur
Date de dépôt 2021-05-18
Date de la première publication 2022-02-08
Date d'octroi 2022-02-08
Propriétaire
  • ChromaDex Inc. (USA)
  • The Queen's University of Belfast (Royaume‑Uni)
Inventeur(s)
  • Migaud, Marie Eugenie
  • Redpath, Philip
  • Crossey, Kerri
  • Cunningham, Richard
  • Erickson, Aron
  • Nygaard, Richard
  • Storjohann, Amanda

Abrégé

The present disclosure provides methods of making nicotinoyl riboside compounds or derivatives of formula (I): 8 are described herein, reduced analogs thereof, modified derivatives thereof, phosphorylated analogs thereof, and adenylyl dinucleotide conjugates thereof, or salts, solvates, or prodrugs thereof, and novel crystalline forms thereof.

Classes IPC  ?

  • C07H 19/048 - Radicaux pyridine
  • C07D 307/20 - Atomes d'oxygène
  • C07H 19/20 - Radicaux purine avec le radical saccharide estérifié par des acides phosphoriques ou polyphosphoriques
  • C07H 19/04 - Radicaux hétérocycliques contenant uniquement des atomes d'azote comme hétéro-atomes du cycle

30.

TRU NIAGEN

      
Numéro de série 97248213
Statut En instance
Date de dépôt 2022-02-01
Propriétaire ChromaDex, Inc. ()
Classes de Nice  ? 30 - Aliments de base, thé, café, pâtisseries et confiseries

Produits et services

Sweets; ice cream; ice cream mixes; ice cream desserts; ice cream substitute; frozen dessert, namely, frozen confections and frozen dessert consisting of cream or cream substitutes; ice cream, cream, and cream-substitute based desserts, edible ices, and ice creams with chocolate, fruit, or tea flavoring; ice cream, cream, and cream-substitute based desserts, edible ices, and ice creams containing dietary and nutritional supplements

31.

Efficient and scalable syntheses of nicotinoyl ribosides and reduced nicotinoyl ribosides, modified derivatives thereof, phosphorylated analogs thereof, adenylyl dinucleotide conjugates thereof, and novel crystalline forms thereof

      
Numéro d'application 17246090
Numéro de brevet 11274117
Statut Délivré - en vigueur
Date de dépôt 2021-04-30
Date de la première publication 2021-11-25
Date d'octroi 2022-03-15
Propriétaire
  • ChromaDex Inc. (USA)
  • The Queen's University of Belfast (Royaume‑Uni)
Inventeur(s)
  • Migaud, Marie Eugenie
  • Redpath, Philip
  • Crossey, Kerri
  • Cunningham, Richard
  • Erickson, Aron
  • Nygaard, Richard
  • Storjohann, Amanda

Abrégé

The present disclosure provides methods of making nicotinoyl riboside compounds or derivatives of formula (I): 8 are described herein, reduced analogs thereof, modified derivatives thereof, phosphorylated analogs thereof, and adenylyl dinucleotide conjugates thereof, or salts, solvates, or prodrugs thereof; and novel crystalline forms thereof.

Classes IPC  ?

  • A01N 43/04 - Biocides, produits repoussant ou attirant les animaux nuisibles, ou régulateurs de croissance des végétaux, contenant des composés hétérocycliques comportant des cycles avec un ou plusieurs atomes d'oxygène ou de soufre comme uniques hétéro-atomes du cycle avec un hétéro-atome
  • A61K 31/70 - Hydrates de carboneSucresLeurs dérivés
  • C07H 19/048 - Radicaux pyridine
  • C07D 307/20 - Atomes d'oxygène
  • C07H 19/20 - Radicaux purine avec le radical saccharide estérifié par des acides phosphoriques ou polyphosphoriques
  • C07H 19/04 - Radicaux hétérocycliques contenant uniquement des atomes d'azote comme hétéro-atomes du cycle

32.

Efficient and scalable syntheses of nicotinoyl ribosides and reduced nicotinoyl ribosides, modified derivatives thereof, phosphorylated analogs thereof, adenylyl dinucleotide conjugates thereof, and novel crystalline forms thereof

      
Numéro d'application 16908416
Numéro de brevet 11746123
Statut Délivré - en vigueur
Date de dépôt 2020-06-22
Date de la première publication 2021-11-11
Date d'octroi 2023-09-05
Propriétaire
  • The Queen's University of Belfast (Royaume‑Uni)
  • ChromaDex Inc. (USA)
Inventeur(s)
  • Migaud, Marie Eugenie
  • Redpath, Philip
  • Crossey, Kerri
  • Cunningham, Richard
  • Erickson, Aron
  • Nygaard, Richard
  • Storjohann, Amanda

Abrégé

The present disclosure provides methods of making nicotinoyl riboside compounds or derivatives of formula (I): 8 are described herein, reduced analogs thereof, modified derivatives thereof, phosphorylated analogs thereof, and adenylyl dinucleotide conjugates thereof, or salts, solvates, or prodrugs thereof; and novel crystalline forms thereof.

Classes IPC  ?

  • C07H 19/048 - Radicaux pyridine
  • C07D 307/20 - Atomes d'oxygène
  • C07H 19/20 - Radicaux purine avec le radical saccharide estérifié par des acides phosphoriques ou polyphosphoriques
  • C07H 19/04 - Radicaux hétérocycliques contenant uniquement des atomes d'azote comme hétéro-atomes du cycle

33.

Use of nicotinamide riboside, nicotinic acid riboside, and nicotinamide mononucleotide, reduced nicotinyl compounds, and nicotinoyl compound derivatives in infant formula for healthy development

      
Numéro d'application 17114864
Numéro de brevet 11524022
Statut Délivré - en vigueur
Date de dépôt 2020-12-08
Date de la première publication 2021-07-29
Date d'octroi 2022-12-13
Propriétaire ChromaDex Inc. (USA)
Inventeur(s)
  • Dellinger, Ryan
  • Rhonemus, Troy
  • Morris, Mark
  • Conze, Dietrich
  • Boileau, Amy

Abrégé

Methods for delivering at least one compound selected from nicotinamide riboside (NR), nicotinic acid riboside (NAR), and nicotinamide mononucleotide (NMN), derivatives thereof, or salts thereof, in combination with at least one of thiamine (vitamin B1), riboflavin (vitamin B2), niacin (vitamin B3), and pyridoxine (vitamin B6), to an infant human subject in need of said compound or compounds are provided.

Classes IPC  ?

  • A61K 31/706 - Composés ayant des radicaux saccharide et des hétérocycles ayant l'azote comme hétéro-atome d'un cycle, p. ex. nucléosides, nucléotides contenant des cycles à six chaînons avec l'azote comme hétéro-atome d'un cycle
  • A61K 31/51 - Thiamines, p. ex. vitamine B1
  • A23L 33/10 - Modification de la qualité nutritive des alimentsProduits diététiquesLeur préparation ou leur traitement en utilisant des additifs
  • A61K 31/4415 - Pyridoxine, c.-à-d. vitamine B6
  • A61K 31/455 - Acide nicotinique, c.-à-d. niacineSes dérivés, p. ex. esters, amides
  • A61K 31/525 - Iso-alloxazines, p. ex. riboflavines, vitamine B2
  • A61K 31/7064 - Composés ayant des radicaux saccharide et des hétérocycles ayant l'azote comme hétéro-atome d'un cycle, p. ex. nucléosides, nucléotides contenant des cycles à six chaînons avec l'azote comme hétéro-atome d'un cycle contenant des pyrimidines condensées ou non-condensées
  • A23L 33/19 - Protéines du lait
  • A23L 33/00 - Modification de la qualité nutritive des alimentsProduits diététiquesLeur préparation ou leur traitement
  • A23L 33/15 - Vitamines
  • A61K 47/42 - ProtéinesPolypeptidesLeurs produits de dégradationLeurs dérivés p. ex. albumine, gélatine ou zéine
  • A61K 45/06 - Mélanges d'ingrédients actifs sans caractérisation chimique, p. ex. composés antiphlogistiques et pour le cœur

34.

SUPERCHARGE YOUR CELLS

      
Numéro de série 90806573
Statut En instance
Date de dépôt 2021-07-01
Propriétaire ChromaDex, Inc. ()
Classes de Nice  ? 35 - Publicité; Affaires commerciales

Produits et services

On-line retail store services featuring dietary and nutritional supplements; Retail store services featuring dietary and nutritional supplements

35.

AGE BETTER

      
Numéro d'application 1583567
Statut Enregistrée
Date de dépôt 2021-02-09
Date d'enregistrement 2021-02-09
Propriétaire ChromaDex, Inc. (USA)
Classes de Nice  ? 05 - Produits pharmaceutiques, vétérinaires et hygièniques

Produits et services

Nutraceuticals for use as a dietary supplement; vitamin and mineral supplements; vitamins.

36.

AboutNAD

      
Numéro d'application 1584241
Statut Enregistrée
Date de dépôt 2020-11-21
Date d'enregistrement 2020-11-21
Propriétaire ChromaDex, Inc. (USA)
Classes de Nice  ?
  • 41 - Éducation, divertissements, activités sportives et culturelles
  • 42 - Services scientifiques, technologiques et industriels, recherche et conception

Produits et services

Providing educational information in the field of clinical research via a website. Medical and scientific research information in the field of cellular energy, nicotinamide adenine dinucleotide, and nicotinamide riboside; providing scientific information in the field of research regarding cellular energy, nicotinamide adenine dinucleotide, and nicotinamide riboside; providing scientific research information in the field of clinical studies.

37.

SUPERCHARGED BY TRU NIAGEN

      
Numéro de série 90609075
Statut En instance
Date de dépôt 2021-03-29
Propriétaire ChromaDex, Inc. ()
Classes de Nice  ?
  • 05 - Produits pharmaceutiques, vétérinaires et hygièniques
  • 35 - Publicité; Affaires commerciales

Produits et services

Dietary and nutritional supplements On-line retail store services featuring dietary and nutritional supplements; Retail store services featuring dietary and nutritional supplements

38.

CHROMADEX

      
Numéro d'application 018349075
Statut Enregistrée
Date de dépôt 2020-12-04
Date d'enregistrement 2022-09-16
Propriétaire ChromaDex, Inc. (USA)
Classes de Nice  ? 05 - Produits pharmaceutiques, vétérinaires et hygièniques

Produits et services

Diagnostic test kits, other than for veterinary purposes; diagnostic preparations, agents, and substances for humans; dietary supplements for humans; nutritional supplements for humans; vitamins for humans; dietary supplement drink mix for humans; nutritional supplement drink mix for humans.

39.

ABOUTNAD

      
Numéro de série 90333539
Statut Enregistrée
Date de dépôt 2020-11-20
Date d'enregistrement 2021-08-03
Propriétaire ChromaDex, Inc. ()
Classes de Nice  ? 42 - Services scientifiques, technologiques et industriels, recherche et conception

Produits et services

Medical and scientific research information in the field of cellular energy, nicotinamide adenine dinucleotide, and nicotinamide riboside; Providing scientific information in the field of research regarding cellular energy, nicotinamide adenine dinucleotide, and nicotinamide riboside; Providing scientific research information in the field of clinical studies; Providing a website featuring educational information in the field of clinical research

40.

ADDING HEALTH TO YEARS

      
Numéro de série 90303248
Statut Enregistrée
Date de dépôt 2020-11-06
Date d'enregistrement 2022-06-21
Propriétaire ChromaDex, Inc. ()
Classes de Nice  ?
  • 05 - Produits pharmaceutiques, vétérinaires et hygièniques
  • 35 - Publicité; Affaires commerciales

Produits et services

Dietary and nutritional supplements On-line retail store services featuring dietary and nutritional supplements; Retail store services featuring dietary and nutritional supplements

41.

Nicotinamide riboside compositions for topical use in treating skin conditions

      
Numéro d'application 16891824
Numéro de brevet 11033568
Statut Délivré - en vigueur
Date de dépôt 2020-06-03
Date de la première publication 2020-09-17
Date d'octroi 2021-06-15
Propriétaire ChromaDex Inc. (USA)
Inventeur(s)
  • Deren-Lewis, Ann
  • Rhonemus, Troy

Abrégé

Compositions containing nicotinamide riboside (NR) are provided. NR containing compositions are used in the care or treatment of skin and skin conditions. In some embodiments, the invention relates to pharmaceutical compositions and cosmetic compositions containing nicotinamide riboside. In further embodiments, the invention relates to methods of using nicotinamide riboside to promote the increase of intracellular levels of nicotinamide adenine dinucleotide (NAD+) in cells and tissues for improving cell and tissue survival. A method of treating signs or symptoms of aging or skin wrinkles in an individual is provided, comprising topically administering to the individual in need of such treatment an effective amount of the compound nicotinamide riboside, or salts thereof.

Classes IPC  ?

  • A61K 31/706 - Composés ayant des radicaux saccharide et des hétérocycles ayant l'azote comme hétéro-atome d'un cycle, p. ex. nucléosides, nucléotides contenant des cycles à six chaînons avec l'azote comme hétéro-atome d'un cycle

42.

USE OF NICOTINAMIDE RIBOSIDE, NICOTINIC ACID RIBOSIDE, REDUCED NICOTINYL RIBOSIDE COMPOUNDS, AND NICOTINYL RIBOSIDE COMPOUND DERIVATIVES IN FORMULATIONS

      
Numéro d'application 16798207
Statut En instance
Date de dépôt 2020-02-21
Date de la première publication 2020-08-27
Propriétaire CHROMADEX INC. (USA)
Inventeur(s)
  • Erickson, Aron
  • Storjohann, Amanda
  • Redpath, Philip
  • Roberts, Matthew

Abrégé

Methods for stabilizing or encapsulating at least one compound selected from the group consisting of nicotinamide riboside (NR), nicotinic acid riboside (NAR), nicotinamide mononucleotide (NMN), nicotinic acid mononucleotide (NaMN), derivatives thereof, or salts thereof, are provided. Compositions including wax prills, stabilized, or encapsulated forms of at least one compound selected from the group consisting of nicotinamide riboside (NR), nicotinic acid riboside (NAR), and nicotinamide mononucleotide (NMN), derivatives thereof, or salts thereof, are also provided.

Classes IPC  ?

  • A61K 31/706 - Composés ayant des radicaux saccharide et des hétérocycles ayant l'azote comme hétéro-atome d'un cycle, p. ex. nucléosides, nucléotides contenant des cycles à six chaînons avec l'azote comme hétéro-atome d'un cycle
  • A61K 9/00 - Préparations médicinales caractérisées par un aspect particulier
  • A61K 47/44 - Huiles, graisses ou cires couvertes par plus d’un des groupes Huiles, graisses ou cires naturelles ou naturelles modifiées, p. ex. huile de ricin, huile de ricin polyéthoxylée, cire de lignite, lignite, gomme-laque, colophane, cire d’abeille ou lanoline
  • A61K 9/14 - Préparations médicinales caractérisées par un aspect particulier à l'état particulaire, p. ex. poudres
  • A61K 45/06 - Mélanges d'ingrédients actifs sans caractérisation chimique, p. ex. composés antiphlogistiques et pour le cœur

43.

USE OF NICOTINAMIDE RIBOSIDE, NICOTINIC ACID RIBOSIDE, REDUCED NICOTINYL RIBOSIDE COMPOUNDS, AND NICOTINYL RIBOSIDE COMPOUND DERIVATIVES IN FORMULATIONS

      
Numéro d'application US2020019361
Numéro de publication 2020/172629
Statut Délivré - en vigueur
Date de dépôt 2020-02-21
Date de publication 2020-08-27
Propriétaire CHROMADEX INC. (USA)
Inventeur(s)
  • Erickson, Aron
  • Storjohann, Amanda
  • Redpath, Philip
  • Roberts, Matthew

Abrégé

Methods for stabilizing or encapsulating at least one compound selected from the group consisting of nicotinamide riboside (NR), nicotinic acid riboside (NAR), nicotinamide mononucleotide (NMN), nicotinic acid mononucleotide (NaMN), derivatives thereof, or salts thereof, are provided. Compositions including wax prills, stabilized, or encapsulated forms of at least one compound selected from the group consisting of nicotinamide riboside (NR), nicotinic acid riboside (NAR), and nicotinamide mononucleotide (NMN), derivatives thereof, or salts thereof, are also provided.

Classes IPC  ?

  • C07H 19/048 - Radicaux pyridine
  • A61K 31/7052 - Composés ayant des radicaux saccharide et des hétérocycles ayant l'azote comme hétéro-atome d'un cycle, p. ex. nucléosides, nucléotides
  • A61K 31/706 - Composés ayant des radicaux saccharide et des hétérocycles ayant l'azote comme hétéro-atome d'un cycle, p. ex. nucléosides, nucléotides contenant des cycles à six chaînons avec l'azote comme hétéro-atome d'un cycle
  • A61K 31/44 - Pyridines non condenséesLeurs dérivés hydrogénés
  • C07H 19/04 - Radicaux hétérocycliques contenant uniquement des atomes d'azote comme hétéro-atomes du cycle

44.

CRYSTALLINE FORMS OF NICOTINOYL RIBOSIDES AND DERIVATIVES THEREOF, AND METHODS OF PREPARATION THEREOF

      
Numéro d'application US2019065456
Numéro de publication 2020/123488
Statut Délivré - en vigueur
Date de dépôt 2019-12-10
Date de publication 2020-06-18
Propriétaire CHROMADEX INC. (USA)
Inventeur(s)
  • Rhonemus, Troy
  • Erickson, Aron
  • Storjohann, Amanda
  • Holloway, Joshua
  • Redpath, Philip

Abrégé

The present disclosure provides crystalline Form II of nicotinic acid riboside, crystalline Form II of nicotinic acid riboside triacetate, and methods of preparation thereof. In an embodiment, the present disclosure relates to crystalline forms of nicotinoyl ribosides, derivatives thereof, or salts, hydrates, solvates, or prodrugs thereof. In another embodiment, the present disclosure relates to synthetic sequences or processes that enable the efficient production of crystalline forms of nicotinoyl ribosides, derivatives thereof, or salts, hydrates, solvates, or prodrugs thereof.

Classes IPC  ?

  • A61K 31/443 - Pyridines non condenséesLeurs dérivés hydrogénés contenant d'autres systèmes hétérocycliques contenant un cycle à cinq chaînons avec l'oxygène comme hétéro-atome du cycle
  • A61K 31/455 - Acide nicotinique, c.-à-d. niacineSes dérivés, p. ex. esters, amides
  • C07D 307/20 - Atomes d'oxygène
  • C07H 19/048 - Radicaux pyridine

45.

Crystalline forms of nicotinoyl ribosides and derivatives thereof, and methods of preparation thereof

      
Numéro d'application 16709060
Numéro de brevet 11214589
Statut Délivré - en vigueur
Date de dépôt 2019-12-10
Date de la première publication 2020-06-11
Date d'octroi 2022-01-04
Propriétaire ChromaDex Inc. (USA)
Inventeur(s)
  • Rhonemus, Troy
  • Erickson, Aron
  • Storjohann, Amanda
  • Holloway, Joshua
  • Redpath, Philip

Abrégé

The present disclosure provides crystalline Form II of nicotinic acid riboside, crystalline Form II of nicotinic acid riboside triacetate, and methods of preparation thereof.

Classes IPC  ?

  • A01N 43/04 - Biocides, produits repoussant ou attirant les animaux nuisibles, ou régulateurs de croissance des végétaux, contenant des composés hétérocycliques comportant des cycles avec un ou plusieurs atomes d'oxygène ou de soufre comme uniques hétéro-atomes du cycle avec un hétéro-atome
  • A61K 31/70 - Hydrates de carboneSucresLeurs dérivés
  • C07H 19/048 - Radicaux pyridine

46.

ABOUTNAD

      
Numéro de série 88929471
Statut Enregistrée
Date de dépôt 2020-05-22
Date d'enregistrement 2020-11-24
Propriétaire ChromaDex, Inc. ()
Classes de Nice  ? 42 - Services scientifiques, technologiques et industriels, recherche et conception

Produits et services

Medical and scientific research information in the field of cellular energy, nicotinamide adenine dinucleotide, and nicotinamide riboside; Providing scientific information in the field of research regarding cellular energy, nicotinamide adenine dinucleotide, and nicotinamide riboside; Providing scientific research information in the field of clinical studies; Providing a website featuring educational information in the field of clinical research

47.

TRU BELIEVER

      
Numéro de série 88897727
Statut Enregistrée
Date de dépôt 2020-05-01
Date d'enregistrement 2023-03-28
Propriétaire ChromaDex, Inc. ()
Classes de Nice  ? 35 - Publicité; Affaires commerciales

Produits et services

On-line retail store services featuring dietary and nutritional supplements; Retail store services featuring dietary and nutritional supplements

48.

Miscellaneous Design

      
Numéro de série 88424739
Statut Enregistrée
Date de dépôt 2019-05-10
Date d'enregistrement 2023-10-10
Propriétaire ChromaDex, Inc. ()
Classes de Nice  ?
  • 41 - Éducation, divertissements, activités sportives et culturelles
  • 44 - Services médicaux, services vétérinaires, soins d'hygiène et de beauté; services d'agriculture, d'horticulture et de sylviculture.

Produits et services

Providing information about fitness, exercise, and workouts; On-line journals, namely, blogs featuring articles, information, in the field of health, fitness, exercise, workouts, wellness, lifestyle, and nutrition Providing information about health, lifestyle wellness, and nutrition

49.

B-vitamin and amino acid conjugates of nicotinoyl ribosides and reduced nicotinoyl ribosides, derivatives thereof, and methods of preparation thereof

      
Numéro d'application 15977851
Numéro de brevet 10934322
Statut Délivré - en vigueur
Date de dépôt 2018-05-11
Date de la première publication 2018-09-13
Date d'octroi 2021-03-02
Propriétaire
  • ChromaDex Inc. (USA)
  • The Queen's University of Belfast (Royaume‑Uni)
Inventeur(s)
  • Migaud, Marie Eugenie
  • Redpath, Philip
  • Crossey, Kerri
  • Cunningham, Richard
  • Dellinger, Ryan
  • Rhonemus, Troy
  • Venkataraman, Sylesh
  • Nettles, Brian

Abrégé

The present disclosure provides nicotinate/nicotinamide riboside compounds or derivatives of formula (I): 8 are described herein, reduced analogs thereof, and synthetic processes for the preparation thereof.

Classes IPC  ?

  • C07H 19/00 - Composés contenant un hétérocycle partageant un hétéro-atome du cycle avec un radical saccharideNucléosidesMononucléotidesLeurs anhydro-dérivés
  • C07H 19/048 - Radicaux pyridine
  • C07H 1/00 - Procédés de préparation des dérivés du sucre
  • C07H 19/04 - Radicaux hétérocycliques contenant uniquement des atomes d'azote comme hétéro-atomes du cycle

50.

NIAGEN

      
Numéro d'application 1415549
Statut Enregistrée
Date de dépôt 2018-03-08
Date d'enregistrement 2018-03-08
Propriétaire ChromaDex, Inc. (USA)
Classes de Nice  ?
  • 01 - Produits chimiques destinés à l'industrie, aux sciences ainsi qu'à l'agriculture
  • 05 - Produits pharmaceutiques, vétérinaires et hygièniques
  • 09 - Appareils et instruments scientifiques et électriques
  • 41 - Éducation, divertissements, activités sportives et culturelles

Produits et services

Phytochemicals for use in the manufacturing of dietary supplements, nutritional products, pharmaceuticals and cosmetics; chemical reagents for non-medical purposes; chemical test kits, comprised of chemical reagents, for analytical measurement of raw material identity, potency and formulation consistency for laboratory or research use; chemicals for use in industry and science; chemicals for use in the biochemical and chemical industry; assays for research purposes; diagnostic preparations for scientific or research use and for health assessment. Diagnostic kits consisting primarily of monoclonal antibodies, buffers, and reagents for use in disease testing; diagnostic preparations for medical purposes; diagnostic agents, preparations and substances for medical purposes; dietary supplements and preparations; medical and veterinary preparations and articles; nutritional supplements. Downloadable mobile applications for managing and sharing information on one's health, fitness and nutrition; downloadable software in the nature of a mobile application for providing information in the fields of health, fitness, exercise, workouts, wellness, lifestyle, healthy eating and nutrition; downloadable mobile application software for the purpose of tracking and monitoring health, wellness and nutrition; computer software for providing information in the fields of health, fitness, exercise, workouts, wellness, lifestyle, healthy eating and nutrition. Providing information about fitness, exercise, and workouts; on-line journals, namely, blogs featuring articles, information, reviews and recipes in the field of health, fitness, exercise, workouts, wellness, lifestyle, healthy eating and nutrition.

51.

NIAGEN

      
Numéro d'application 1403232
Statut Enregistrée
Date de dépôt 2018-02-14
Date d'enregistrement 2018-02-14
Propriétaire ChromaDex, Inc. (USA)
Classes de Nice  ? 05 - Produits pharmaceutiques, vétérinaires et hygièniques

Produits et services

Diagnostic kits consisting primarily of monoclonal antibodies, buffers, and reagents for use in disease testing; diagnostic preparations for medical purposes; diagnostic agents, preparations and substances for medical purposes; dietary supplements and preparations; medical and veterinary preparations and articles; nutritional supplements; dietary and nutritional supplements.

52.

Crystalline forms of nicotinoyl ribosides, modified derivatives thereof, and phosphorylated analogs thereof, and methods of preparation thereof

      
Numéro d'application 15809731
Numéro de brevet 09975915
Statut Délivré - en vigueur
Date de dépôt 2017-11-10
Date de la première publication 2018-05-17
Date d'octroi 2018-05-22
Propriétaire
  • The Queen's University of Belfast (Royaume‑Uni)
  • ChromaDex Inc. (USA)
Inventeur(s)
  • Migaud, Marie Eugenie
  • Redpath, Philip
  • Crossey, Kerri
  • Cunningham, Richard
  • Erickson, Aron
  • Nygaard, Richard
  • Storjohann, Amanda

Abrégé

The present disclosure provides novel crystalline forms of nicotinoyl riboside compounds or derivatives of formula (I): 8 are described herein, modified derivatives thereof, and phosphorylated analogs thereof, or salts, solvates, or prodrugs thereof; and methods of preparation thereof.

Classes IPC  ?

  • C07H 19/04 - Radicaux hétérocycliques contenant uniquement des atomes d'azote comme hétéro-atomes du cycle
  • C07H 19/048 - Radicaux pyridine

53.

Efficient and scalable syntheses of nicotinoyl ribosides and reduced nicotinoyl ribosides, modified derivatives thereof, phosphorylated analogs thereof, adenylyl dinucleotide conjugates thereof, and novel crystalline forms thereof

      
Numéro d'application 15809753
Numéro de brevet 10689411
Statut Délivré - en vigueur
Date de dépôt 2017-11-10
Date de la première publication 2018-05-17
Date d'octroi 2020-06-23
Propriétaire
  • The Queen's University of Belfast (Royaume‑Uni)
  • ChromaDex Inc. (USA)
Inventeur(s)
  • Migaud, Marie Eugenie
  • Redpath, Philip
  • Crossey, Kerri
  • Cunningham, Richard
  • Erickson, Aron
  • Nygaard, Richard
  • Storjohann, Amanda

Abrégé

The present disclosure provides methods of making nicotinoyl riboside compounds or derivatives of formula (I): 8 are described herein, reduced analogs thereof, modified derivatives thereof, phosphorylated analogs thereof, and adenylyl dinucleotide conjugates thereof, or salts, solvates, or prodrugs thereof; and novel crystalline forms thereof.

Classes IPC  ?

  • C07H 19/207 - Radicaux purine avec le radical saccharide estérifié par des acides phosphoriques ou polyphosphoriques les acides phosphoriques ou polyphosphoriques étant estérifiés par un autre composé hydroxylique, p. ex. les dinucléotides de la flavine-adénine ou de la nicotinamide-adénine
  • C07H 19/048 - Radicaux pyridine
  • C07D 307/20 - Atomes d'oxygène
  • C07H 19/20 - Radicaux purine avec le radical saccharide estérifié par des acides phosphoriques ou polyphosphoriques
  • C07H 19/04 - Radicaux hétérocycliques contenant uniquement des atomes d'azote comme hétéro-atomes du cycle

54.

EFFICIENT AND SCALABLE SYNTHESES OF NICOTINOYL RIBOSIDES AND REDUCED NICOTINOYL RIBOSIDES, MODIFIED DERIVATIVES THEREOF, PHOSPHORYLATED ANALOGS THEREOF, ADENYLYL DINUCLEOTIDE CONJUGATES THEREOF, AND NOVEL CRYSTALLINE FORMS THEREOF

      
Numéro d'application US2017061154
Numéro de publication 2018/089830
Statut Délivré - en vigueur
Date de dépôt 2017-11-10
Date de publication 2018-05-17
Propriétaire
  • THE QUEEN'S UNIVERSITY OF BELFAST (Royaume‑Uni)
  • CHROMADEX INC. (USA)
Inventeur(s)
  • Migaud, Marie, Eugenie
  • Redpath, Philip
  • Crossey, Kerri
  • Cunningham, Richard
  • Erickson, Aron
  • Nygaard, Richard
  • Storjohann, Amanda

Abrégé

The present disclosure provides methods of making nicotinoyl riboside compounds or derivatives of formula (I): wherein X", Z 1, Z2, n, R 1, R2, R3, R4, R5, R6,, R7, and R 8 are described herein, reduced analogs thereof, modified derivatives thereof, phosphorylated analogs thereof, and adenylyl dinucleotide conjugates thereof, or salts, solvates, or prodrugs thereof; and novel crystalline forms thereof.

Classes IPC  ?

  • A61K 31/455 - Acide nicotinique, c.-à-d. niacineSes dérivés, p. ex. esters, amides
  • A61K 31/706 - Composés ayant des radicaux saccharide et des hétérocycles ayant l'azote comme hétéro-atome d'un cycle, p. ex. nucléosides, nucléotides contenant des cycles à six chaînons avec l'azote comme hétéro-atome d'un cycle
  • C07H 1/00 - Procédés de préparation des dérivés du sucre
  • C07H 19/048 - Radicaux pyridine

55.

TRU NIAGEN

      
Numéro d'application 1393923
Statut Enregistrée
Date de dépôt 2017-11-21
Date d'enregistrement 2017-11-21
Propriétaire ChromaDex, Inc. (USA)
Classes de Nice  ?
  • 01 - Produits chimiques destinés à l'industrie, aux sciences ainsi qu'à l'agriculture
  • 05 - Produits pharmaceutiques, vétérinaires et hygièniques
  • 09 - Appareils et instruments scientifiques et électriques
  • 41 - Éducation, divertissements, activités sportives et culturelles

Produits et services

Phytochemicals for use in the manufacturing of dietary supplements, nutritional products, pharmaceuticals and cosmetics; chemical reagents for non-medical purposes; chemical test kits, comprised of chemical reagents, for analytical measurement of raw material identity, potency and formulation consistency for laboratory or research use; chemicals for use in industry and science; chemicals for use in the biochemical and chemical industry; assays for research purposes; diagnostic preparations for scientific or research use. Dietary and nutritional supplements; diagnostic kits consisting of monoclonal antibodies, buffers, and reagents for use in disease testing; diagnostic preparations for medical purposes; diagnostic agents, preparations and substances for medical purposes; dietary supplements and preparations; medical and veterinary preparations and articles; nutritional supplements. Downloadable mobile applications for managing and sharing information on one's health, fitness and nutrition; downloadable software in the nature of a mobile application providing information in the fields of health, fitness, exercise, workouts, wellness, lifestyle, healthy eating and nutrition; downloadable mobile application software for the purpose of tracking and monitoring health, wellness and nutrition; computer software for providing information in the fields of health, fitness, exercise, workouts, wellness, lifestyle, healthy eating and nutrition. Providing information about health, fitness, exercise, workouts, wellness, lifestyle, healthy eating and nutrition; publication of on-line journals, namely, blogs featuring articles, information, reviews and recipes in the field of health, fitness, exercise, workouts, wellness, lifestyle, healthy eating and nutrition.

56.

CHROMADEX

      
Numéro de série 87753883
Statut Enregistrée
Date de dépôt 2018-01-12
Date d'enregistrement 2022-04-26
Propriétaire ChromaDex Inc. ()
Classes de Nice  ?
  • 01 - Produits chimiques destinés à l'industrie, aux sciences ainsi qu'à l'agriculture
  • 05 - Produits pharmaceutiques, vétérinaires et hygièniques
  • 41 - Éducation, divertissements, activités sportives et culturelles
  • 44 - Services médicaux, services vétérinaires, soins d'hygiène et de beauté; services d'agriculture, d'horticulture et de sylviculture.

Produits et services

Phytochemicals for use in the manufacturing of dietary supplements, nutritional products, pharmaceuticals; Chemical reagents for non-medical purposes; Chemicals for use in industry and science; Chemicals for use in the biochemical and chemical industry; Assays for research purposes; Diagnostic preparations for scientific or research use Dietary and nutritional supplements Providing information about fitness, exercise, and workouts; Providing a website featuring on-line journals in the nature of non-downloadable articles in the field of health, fitness, exercise, workouts, wellness, lifestyle, healthy eating and nutrition; Providing information and reviews about physical fitness, exercise and fitness workouts Providing information about health, lifestyle wellness, healthy eating and nutrition

57.

TRU NIAGEN

      
Numéro d'application 187123700
Statut Enregistrée
Date de dépôt 2017-12-04
Date d'enregistrement 2020-09-23
Propriétaire ChromaDex Inc. (USA)
Classes de Nice  ?
  • 01 - Produits chimiques destinés à l'industrie, aux sciences ainsi qu'à l'agriculture
  • 05 - Produits pharmaceutiques, vétérinaires et hygièniques
  • 09 - Appareils et instruments scientifiques et électriques
  • 44 - Services médicaux, services vétérinaires, soins d'hygiène et de beauté; services d'agriculture, d'horticulture et de sylviculture.

Produits et services

(1) Phytochemical additives for use in the manufacturing of dietary supplements, nutritional products, pharmaceuticals and cosmetics; chemical reagents for non-medical purposes for use in the dietary and nutritional supplement industry; chemical test kits for analytical measurement of raw material identity, potency and formulation consistency for laboratory or research use; chemical additives for use in the manufacture of dietary and nutritional supplements; chemical compositions for use in dietary and nutritional supplements; assays for research purposes for use in the development of dietary and nutritional supplements (2) Dietary and nutritional supplements for general health and well-being (3) Diagnostic kits consisting primarily of monoclonal antibodies, buffers, and reagents for use in disease testing; diagnostic preparations for medical purposes for improvement of one's general health and wellbeing; diagnostic agents, preparations and substances for medical purposes for improvement of general health and well-being; dietary supplements and preparations for general health and well-being; medical preparations for improvement of general health and well-being and veterinary preparations for improvement of general health and well-being (4) Diagnostic preparations for improvement of general health and well-being (5) Downloadable mobile applications for managing and sharing information on one's general health, fitness and nutrition; downloadable software in the nature of a mobile application providing information in the fields of general health, fitness, exercise, workouts, well-being, personal lifestyle, healthy eating and nutrition; downloadable mobile application software for the purpose of tracking and monitoring general health, wellbeing and nutrition; computer software for providing information in the fields of general health, fitness, exercise, workouts, well-being, personal lifestyle, healthy eating and nutrition (1) Providing information about general health, fitness, exercise, workouts, well-being, personal lifestyle, healthy eating and nutrition; on-line journals, namely, blogs featuring articles, information, reviews and recipes in the field of general health, fitness, exercise, workouts, well-being, personal lifestyle, healthy eating and nutrition

58.

NIAGEN

      
Numéro de série 87695359
Statut Enregistrée
Date de dépôt 2017-11-22
Date d'enregistrement 2022-03-29
Propriétaire ChromaDex Inc. ()
Classes de Nice  ?
  • 01 - Produits chimiques destinés à l'industrie, aux sciences ainsi qu'à l'agriculture
  • 05 - Produits pharmaceutiques, vétérinaires et hygièniques

Produits et services

Phytochemicals for use in the manufacturing of dietary supplements, nutritional products, pharmaceuticals and cosmetics; Chemical reagents for non-medical purposes; Chemicals for use in industry and science; Chemicals for use in the biochemical and chemical industry; Assays for research purposes; Diagnostic preparations for scientific or research use Dietary supplements; Nutritional supplements

59.

Use of nicotinic acid riboside or nicotinamide riboside derivatives, and reduced derivatives thereof, as NAD+ increasing precursors

      
Numéro d'application 15492952
Numéro de brevet 10183036
Statut Délivré - en vigueur
Date de dépôt 2017-04-20
Date de la première publication 2017-10-26
Date d'octroi 2019-01-22
Propriétaire ChromaDex Inc. (USA)
Inventeur(s)
  • Dellinger, Ryan
  • Rhonemus, Troy
  • Morris, Mark
  • Erickson, Aron
  • Casser, Hadi
  • Migaud, Marie Eugenie

Abrégé

Compositions are provided including nicotinic acid riboside (“NAR”), and derivatives thereof including 1-(2′,3′,5′-triacetyl-beta-D-ribofuranosyl)-nicotinic acid (“NAR triacetate” or “NARTA”); or derivatives of a reduced form of nicotinic acid riboside (“NARH”), including 1-(2′,3′,5′-triacetyl-beta-D-ribofuranosyl)-1,4-dihydronicotinic acid (“NARH triacetate” or “NARH-TA”); or derivatives of nicotinamide riboside (“NR”), including 1-(2′,3′,5′-triacetyl-beta-D-ribofuranosyl)-nicotinamide (“NR triacetate” or “NRTA”); derivatives of a reduced form of nicotinamide riboside (“NRH”), including 1-(2′,3′,5′-triacetyl-beta-D-ribofuranosyl)-1,4-dihydronicotinamide (“NRH triacetate” or “NRH-TA”); or salts or prodrugs thereof, for use in food or beverage applications, pharmaceutical formulations, or as a dietary supplement. Methods of using the compounds above to promote the increase of intracellular levels of nicotinamide adenine dinucleotide (“NAD+”) or NADH in cells and tissues for improving cell and tissue survival or overall cell and tissue health are provided.

Classes IPC  ?

  • A01N 43/04 - Biocides, produits repoussant ou attirant les animaux nuisibles, ou régulateurs de croissance des végétaux, contenant des composés hétérocycliques comportant des cycles avec un ou plusieurs atomes d'oxygène ou de soufre comme uniques hétéro-atomes du cycle avec un hétéro-atome
  • A61K 31/70 - Hydrates de carboneSucresLeurs dérivés
  • A61K 31/706 - Composés ayant des radicaux saccharide et des hétérocycles ayant l'azote comme hétéro-atome d'un cycle, p. ex. nucléosides, nucléotides contenant des cycles à six chaînons avec l'azote comme hétéro-atome d'un cycle

60.

USE OF NICOTINIC ACID RIBOSIDE OR NICOTINAMIDE RIBOSIDE DERIVATIVES, AND REDUCED DERIVATIVES THEREOF, AS NAD+ INCREASING PRECURSORS

      
Numéro d'application US2017028673
Numéro de publication 2017/184885
Statut Délivré - en vigueur
Date de dépôt 2017-04-20
Date de publication 2017-10-26
Propriétaire CHROMADEX INC. (USA)
Inventeur(s)
  • Dellinger, Ryan
  • Rhonemus, Troy
  • Morris, Mark
  • Erickson, Aron
  • Casser, Hadi
  • Migaud, Marie, E.

Abrégé

Compositions are provided including nicotinic acid riboside ("NAR"), and derivatives thereof including l -(2',3 ',5'-triacetyl-beta-D-ribofuranosyl)-nicotinic acid ("NAR triacetate" or "NARTA"); or derivatives of a reduced form of nicotinic acid riboside ("NARH"), including 1 - (2',3',5 '-triacetyl-beta-D-ribofuranosyl)-1,4-dihydronicotinic acid ("NARH triacetate" or "NARJT-TA"); or derivatives of nicotinamide riboside ("NR"), including 1 -(2',3',5'-triacetyl- beta-D-ribofuranosyl)-nicotinamide ("NR triacetate" or "NRTA"); derivatives of a reduced form of nicotinamide riboside ("NRH"), including 1-(2',3 ',5'-triacetyl-beta-D-ribofuranosyl)- 1,4- dihydronicotinamide ("NRH triacetate" or "NRH-TA"); or salts or prodrugs thereof, for use in food or beverage applications, pharmaceutical formulations, or as a dietary supplement. Methods of using the compounds above to promote the increase of intracellular levels of nicotinamide adenine dinuc!eotide ("NAD+") or NADH in cells and tissues for improving cell and tissue survival or overall cell and tissue health are provided.

Classes IPC  ?

  • A61K 31/44 - Pyridines non condenséesLeurs dérivés hydrogénés
  • A61K 31/706 - Composés ayant des radicaux saccharide et des hétérocycles ayant l'azote comme hétéro-atome d'un cycle, p. ex. nucléosides, nucléotides contenant des cycles à six chaînons avec l'azote comme hétéro-atome d'un cycle
  • A61K 31/7052 - Composés ayant des radicaux saccharide et des hétérocycles ayant l'azote comme hétéro-atome d'un cycle, p. ex. nucléosides, nucléotides
  • C07H 19/00 - Composés contenant un hétérocycle partageant un hétéro-atome du cycle avec un radical saccharideNucléosidesMononucléotidesLeurs anhydro-dérivés
  • C07H 19/04 - Radicaux hétérocycliques contenant uniquement des atomes d'azote comme hétéro-atomes du cycle
  • C07H 19/048 - Radicaux pyridine

61.

Use of nicotinamide riboside, nicotinic acid riboside, and nicotinamide mononucleotide, reduced nicotinyl compounds, and nicotinoyl compound derivatives in infant formula for healthy development

      
Numéro d'application 15488215
Numéro de brevet 10857172
Statut Délivré - en vigueur
Date de dépôt 2017-04-14
Date de la première publication 2017-10-19
Date d'octroi 2020-12-08
Propriétaire ChromaDex, Inc. (USA)
Inventeur(s)
  • Dellinger, Ryan
  • Rhonemus, Troy
  • Morris, Mark
  • Conze, Dietrich
  • Boileau, Amy

Abrégé

Methods for delivering at least one compound selected from nicotinamide riboside (NR), nicotinic acid riboside (NAR), and nicotinamide mononucleotide (NMN), derivatives thereof, or salts thereof, in combination with at least one of thiamine (vitamin B1), riboflavin (vitamin B2), niacin (vitamin B3), and pyridoxine (vitamin B6), to an infant human subject in need of said compound or compounds are provided.

Classes IPC  ?

  • A61K 31/7064 - Composés ayant des radicaux saccharide et des hétérocycles ayant l'azote comme hétéro-atome d'un cycle, p. ex. nucléosides, nucléotides contenant des cycles à six chaînons avec l'azote comme hétéro-atome d'un cycle contenant des pyrimidines condensées ou non-condensées
  • A23L 33/00 - Modification de la qualité nutritive des alimentsProduits diététiquesLeur préparation ou leur traitement
  • A23L 33/15 - Vitamines
  • A61K 31/706 - Composés ayant des radicaux saccharide et des hétérocycles ayant l'azote comme hétéro-atome d'un cycle, p. ex. nucléosides, nucléotides contenant des cycles à six chaînons avec l'azote comme hétéro-atome d'un cycle
  • A61K 31/51 - Thiamines, p. ex. vitamine B1
  • A23L 33/10 - Modification de la qualité nutritive des alimentsProduits diététiquesLeur préparation ou leur traitement en utilisant des additifs
  • A61K 31/4415 - Pyridoxine, c.-à-d. vitamine B6
  • A61K 31/455 - Acide nicotinique, c.-à-d. niacineSes dérivés, p. ex. esters, amides
  • A61K 31/525 - Iso-alloxazines, p. ex. riboflavines, vitamine B2
  • A23L 33/19 - Protéines du lait
  • A61K 45/06 - Mélanges d'ingrédients actifs sans caractérisation chimique, p. ex. composés antiphlogistiques et pour le cœur
  • A61K 47/42 - ProtéinesPolypeptidesLeurs produits de dégradationLeurs dérivés p. ex. albumine, gélatine ou zéine

62.

USE OF NICOTINAMIDE RIBOSIDE, NICOTINIC ACID RIBOSIDE, NICOTINAMIDE MONONUCLEOTIDE, AND NICOTINOYL COMPOUND DERIVATIVES IN INFANT FORMULA

      
Numéro d'application US2017027755
Numéro de publication 2017/181102
Statut Délivré - en vigueur
Date de dépôt 2017-04-14
Date de publication 2017-10-19
Propriétaire CHROMADEX INC. (USA)
Inventeur(s)
  • Dellinger, Ryan
  • Rhonemus, Troy
  • Morris, Mark
  • Conze, Dietrich
  • Boileau, Amy

Abrégé

Methods for delivering at least one compound selected from nicotinamide riboside (NR), nicotinic acid riboside (NAR), and nicotinamide mononucleotide (NMN), derivatives thereof, or salts thereof, in combination with at least one of thiamine (vitamin Bl), riboflavin (vitamin B2), niacin (vitamin B3), and pyridoxine (vitamin B6), to an infant human subject in need of said compound or compounds are provided.

Classes IPC  ?

  • A61K 31/44 - Pyridines non condenséesLeurs dérivés hydrogénés
  • A61K 31/455 - Acide nicotinique, c.-à-d. niacineSes dérivés, p. ex. esters, amides
  • A61K 31/706 - Composés ayant des radicaux saccharide et des hétérocycles ayant l'azote comme hétéro-atome d'un cycle, p. ex. nucléosides, nucléotides contenant des cycles à six chaînons avec l'azote comme hétéro-atome d'un cycle
  • C07H 7/06 - Radicaux hétérocycliques
  • A23L 33/15 - Vitamines

63.

B-vitamin and amino acid conjugates ofnicotinoyl ribosides and reduced nicotinoyl ribosides, derivatives thereof, and methods of preparation thereof

      
Numéro d'application 15461126
Numéro de brevet 10000520
Statut Délivré - en vigueur
Date de dépôt 2017-03-16
Date de la première publication 2017-09-21
Date d'octroi 2018-06-19
Propriétaire
  • ChromaDex Inc. (USA)
  • The Queen's University of Belfast (Royaume‑Uni)
Inventeur(s)
  • Migaud, Marie Eugenie
  • Redpath, Philip
  • Crossey, Kerri
  • Cunningham, Richard
  • Dellinger, Ryan
  • Rhonemus, Troy
  • Venkataraman, Sylesh
  • Nettles, Brian

Abrégé

The present disclosure provides nicotinate/nicotinamide riboside compounds or derivatives of formula (I): 8 are described herein, reduced analogs thereof, and synthetic processes for the preparation thereof.

Classes IPC  ?

  • C07H 19/00 - Composés contenant un hétérocycle partageant un hétéro-atome du cycle avec un radical saccharideNucléosidesMononucléotidesLeurs anhydro-dérivés
  • C07H 19/048 - Radicaux pyridine
  • C07H 1/00 - Procédés de préparation des dérivés du sucre
  • C07H 19/04 - Radicaux hétérocycliques contenant uniquement des atomes d'azote comme hétéro-atomes du cycle

64.

B-VITAMIN AND AMINO ACID CONJUGATES OF NICOTINOYL RIBOSIDES AND REDUCED NICOTINOYL RIBOSIDES, DERIVATIVES THEREOF, AND METHODS OF PREPARATION THEREOF

      
Numéro d'application US2017022779
Numéro de publication 2017/161165
Statut Délivré - en vigueur
Date de dépôt 2017-03-16
Date de publication 2017-09-21
Propriétaire
  • CHROMADEX INC. (USA)
  • THE QUEEN'S UNIVERSITY OF BELFAST (Royaume‑Uni)
Inventeur(s)
  • Migaud, Marie, Eugenie
  • Redpath, Philip
  • Crossey, Kerri
  • Cunningham, Richard
  • Dellinger, Ryan
  • Rhonemus, Troy
  • Venkataraman, Sylesh
  • Nettles, Brian

Abrégé

The present disclosure provides nicotinate/nicotinamide riboside compounds or derivatives of formula (I): wherein X-, Z1 Z2, n, R1, R2, R3, R4, R5, R6, R7, and R8 are described herein, reduced analogs thereof, and synthetic processes for the preparation thereof.

Classes IPC  ?

  • A01N 43/40 - Biocides, produits repoussant ou attirant les animaux nuisibles, ou régulateurs de croissance des végétaux, contenant des composés hétérocycliques comportant des cycles avec un atome d'azote comme unique hétéro-atome du cycle des cycles à six chaînons
  • A61K 31/44 - Pyridines non condenséesLeurs dérivés hydrogénés

65.

TRU NIAGEN

      
Numéro de série 87982993
Statut Enregistrée
Date de dépôt 2017-06-21
Date d'enregistrement 2020-05-19
Propriétaire ChromaDex Inc. ()
Classes de Nice  ?
  • 41 - Éducation, divertissements, activités sportives et culturelles
  • 44 - Services médicaux, services vétérinaires, soins d'hygiène et de beauté; services d'agriculture, d'horticulture et de sylviculture.

Produits et services

Providing information about fitness, exercise, and workouts; On-line journals, namely, blogs featuring articles, information, reviews and recipes in the field of health, fitness, exercise, workouts, wellness, lifestyle, healthy eating and nutrition Providing information about health, lifestyle wellness, healthy eating and nutrition

66.

TRU NIAGEN

      
Numéro de série 87497901
Statut Enregistrée
Date de dépôt 2017-06-20
Date d'enregistrement 2018-01-02
Propriétaire ChromaDex Inc. ()
Classes de Nice  ? 05 - Produits pharmaceutiques, vétérinaires et hygièniques

Produits et services

Dietary and nutritional supplements

67.

NIAGEN

      
Numéro d'application 1336169
Statut Enregistrée
Date de dépôt 2016-12-15
Date d'enregistrement 2016-12-15
Propriétaire ChromaDex, Inc. (USA)
Classes de Nice  ?
  • 01 - Produits chimiques destinés à l'industrie, aux sciences ainsi qu'à l'agriculture
  • 05 - Produits pharmaceutiques, vétérinaires et hygièniques

Produits et services

Phytochemicals for use in the manufacturing of dietary supplements, nutritional products, pharmaceuticals and cosmetics. Dietary and nutritional supplements.

68.

NIAGEN

      
Numéro d'application 181609500
Statut Enregistrée
Date de dépôt 2016-12-28
Date d'enregistrement 2018-12-18
Propriétaire ChromaDex Inc. (USA)
Classes de Nice  ?
  • 01 - Produits chimiques destinés à l'industrie, aux sciences ainsi qu'à l'agriculture
  • 05 - Produits pharmaceutiques, vétérinaires et hygièniques

Produits et services

(1) Phytochemical additives for use in the manufacturing of dietary supplements, nutritional products, pharmaceuticals and cosmetics (2) Dietary and nutritional supplements for general health and well being

69.

SELECTIVE SOLVENT FREE PHOSPHORYLATION

      
Numéro d'application US2016035729
Numéro de publication 2016/196941
Statut Délivré - en vigueur
Date de dépôt 2016-06-03
Date de publication 2016-12-08
Propriétaire
  • CHROMADEX, INC. (USA)
  • THE QUEEN'S UNIVERSITY OF BELFAST (Royaume‑Uni)
Inventeur(s)
  • Migaud, Marie Eugenie
  • Redpath, Philip
  • Crossey, Kerri
  • Cunningham, Richard
  • Rhonemus, Troy
  • Venkataraman, Sylesh

Abrégé

A synthetic process is provided for the preparation of phosphorylated analogs of nicotinamide riboside ("NR") having the formula (I), or salts thereof, and reduced or modified derivatives thereof, having the formula (II), wherein X-, Y1, Y2, Z1, Z2, n, R1, R2, R3, R4, R5, R6, and R7 are as defined herein. The present disclosure also relates to the preparation of phosphorylated analogs of nicotinic acid riboside ("NAR") having the formula (I), or salts thereof, and reduced or modified derivatives thereof, having the formula (II). Generally solvent-free conditions are employed using appropriate mechano-chemical techniques as described. (I) (II)

Classes IPC  ?

  • A01N 43/40 - Biocides, produits repoussant ou attirant les animaux nuisibles, ou régulateurs de croissance des végétaux, contenant des composés hétérocycliques comportant des cycles avec un atome d'azote comme unique hétéro-atome du cycle des cycles à six chaînons
  • A61K 31/44 - Pyridines non condenséesLeurs dérivés hydrogénés

70.

AGE BETTER

      
Numéro d'application 180884300
Statut Enregistrée
Date de dépôt 2016-11-10
Date d'enregistrement 2018-07-30
Propriétaire ChromaDex, Inc. (USA)
Classes de Nice  ? 05 - Produits pharmaceutiques, vétérinaires et hygièniques

Produits et services

(1) Nutraceuticals for use as a dietary supplement for general health and well-being; vitamin and mineral supplements; vitamins

71.

Nicotinic acid riboside or nicotinamide riboside compositions, reduced derivatives thereof, and the use thereof to enhance skin permeation in treating skin conditions

      
Numéro d'application 15072121
Numéro de brevet 10280190
Statut Délivré - en vigueur
Date de dépôt 2016-03-16
Date de la première publication 2016-09-22
Date d'octroi 2019-05-07
Propriétaire
  • ChromaDex, Inc. (USA)
  • The Queen's University of Belfast (Irlande)
Inventeur(s)
  • Dellinger, Ryan
  • Migaud, Marie Eugenie
  • Redpath, Philip
  • Rhonemus, Troy
  • Cunningham, Richard

Abrégé

Derivatives of nicotinic acid riboside (NAR), nicotinamide riboside (NR), and reduced NAR and NR, including 1-(2′,3′,5′-triacetyl-beta-D-ribofuranosyl)-1,4-dihydronicotinic acid (4a), and compositions containing the same and/or reduced derivative forms of nicotinamide riboside including 1-(2′,3′,5′-triacetyl-beta-D-ribofuranosyl)-1,4-nicotinamide (2), are provided for use in the care of treatment of skin and skin conditions. In some embodiments, the invention relates to pharmaceutical compositions and cosmetic compositions containing one or more NR, NAR, NRH, or NARH derivatives, or prodrugs or salts thereof. In further embodiments, the invention relates to methods of using one or more NR, NAR, NRH, or NARH derivatives, or prodrugs, solvates, or salts thereof, to promote the increase of intracellular levels of nicotinamide adenine dinucleotide (NAD+) in cells and tissues for improving cell and tissue survival and overall cell and tissue health.

Classes IPC  ?

72.

NICOTINIC ACID RIBOSIDE OR NICOTINAMIDE RIBOSIDE COMPOSITIONS, REDUCED DERIVATIVES THEREOF, AND THE USE THEREOF

      
Numéro d'application US2016022682
Numéro de publication 2016/149395
Statut Délivré - en vigueur
Date de dépôt 2016-03-16
Date de publication 2016-09-22
Propriétaire
  • CHROMADEX INC. (USA)
  • THE QUEEN'S UNIVERSITY OF BELFAST (Royaume‑Uni)
Inventeur(s)
  • Dellinger, Ryan
  • Migaud, Marie, Eugenie
  • Redpath, Philip
  • Rhonemus, Troy
  • Cunningham, Richard

Abrégé

Derivatives of nicotinic acid riboside (NAR), nicotinamide riboside (NR), and reduced NAR and NR, including 1-(2', 3', 5'-triacetyl-beta-D-ribofuranosyl)-1,4-dihydronicotinic acid (4a), and compositions containing the same and/or reduced derivative forms of nicotinamide riboside including 1-(2',3',5'-triacetyl-beta-D-ribofuranosyl)-1,4-nicotinamide (2), are provided for use in the care of treatment of skin and skin conditions. In some embodiments, the invention relates to pharmaceutical compositions and cosmetic compositions containing one or more NR, NAR, NRH, or NARH derivatives, or prodrugs or salts thereof. In further embodiments, the invention relates to methods of using one or more NR, NAR, NRH, or NARH derivatives, or prodrugs, solvates, or salts thereof, to promote the increase of intracellular levels of nicotinamide adenine dinucleotide (NAD+) in cells and tissues for improving cell and tissue survival and overall cell and tissue health.

Classes IPC  ?

  • C07H 19/048 - Radicaux pyridine
  • A61K 31/706 - Composés ayant des radicaux saccharide et des hétérocycles ayant l'azote comme hétéro-atome d'un cycle, p. ex. nucléosides, nucléotides contenant des cycles à six chaînons avec l'azote comme hétéro-atome d'un cycle

73.

Nicotinamide riboside compositions for topical use in treating skin conditions

      
Numéro d'application 15033285
Numéro de brevet 10688118
Statut Délivré - en vigueur
Date de dépôt 2014-10-30
Date de la première publication 2016-09-01
Date d'octroi 2020-06-23
Propriétaire ChromaDex Inc. (USA)
Inventeur(s)
  • Deren-Lewis, Ann
  • Rhonemus, Troy

Abrégé

Compositions containing nicotinamide riboside (NR) are provided. NR containing compositions are used in the care or treatment of skin and skin conditions. In some embodiments, the invention relates to pharmaceutical compositions and cosmetic compositions containing nicotinamide riboside. In further embodiments, the invention relates to methods of using nicotinamide riboside to promote the increase of intracellular levels of nicotinamide adenine dinucleotide (NAD+) in cells and tissues for improving cell and tissue survival. A method of treating signs or symptoms of aging or skin wrinkles in an individual is provided, comprising topically administering to the individual in need of such treatment an effective amount of the compound nicotinamide riboside, or salts thereof.

Classes IPC  ?

  • A61K 31/706 - Composés ayant des radicaux saccharide et des hétérocycles ayant l'azote comme hétéro-atome d'un cycle, p. ex. nucléosides, nucléotides contenant des cycles à six chaînons avec l'azote comme hétéro-atome d'un cycle

74.

AGE BETTER

      
Numéro de série 87036537
Statut Enregistrée
Date de dépôt 2016-05-13
Date d'enregistrement 2017-05-09
Propriétaire CHROMADEX, INC. ()
Classes de Nice  ? 05 - Produits pharmaceutiques, vétérinaires et hygièniques

Produits et services

Nutraceuticals for use as a dietary supplement; Vitamin and mineral supplements; Vitamins

75.

NIAGEN

      
Numéro d'application 014042428
Statut Enregistrée
Date de dépôt 2015-05-09
Date d'enregistrement 2017-11-02
Propriétaire ChromaDex, Inc. (USA)
Classes de Nice  ? 05 - Produits pharmaceutiques, vétérinaires et hygièniques

Produits et services

Dietary supplements and dietetic preparations; Medical and veterinary preparations and articles; Nutritional supplements.

76.

NICOTINAMIDE RIBOSIDE COMPOSITIONS FOR TOPICAL USE IN TREATING SKIN CONDITIONS

      
Numéro d'application US2014063260
Numéro de publication 2015/066382
Statut Délivré - en vigueur
Date de dépôt 2014-10-30
Date de publication 2015-05-07
Propriétaire CHROMADEX INC. (USA)
Inventeur(s)
  • Deren-Lewis, Ann
  • Rhonemus, Troy

Abrégé

Compositions containing nicotinamide riboside (NR) are provided. NR containing compositions are used in the care or treatment of skin and skin conditions. In some embodiments, the invention relates to pharmaceutical compositions and cosmetic compositions containing nicotinamide riboside. In further embodiments, the invention relates to methods of using nicotinamide riboside to promote the increase of intracellular levels of nicotinamide adenine dinucleotide (NAD+) in cells and tissues for improving cell and tissue survival. A method of treating signs or symptoms of aging or skin wrinkles in an individual is provided, comprising topically administering to the individual in need of such treatment an effective amount of the compound nicotinamide riboside, or salts thereof.

Classes IPC  ?

77.

C

      
Numéro de série 86588333
Statut Enregistrée
Date de dépôt 2015-04-06
Date d'enregistrement 2015-11-17
Propriétaire ChromaDex Inc. ()
Classes de Nice  ?
  • 01 - Produits chimiques destinés à l'industrie, aux sciences ainsi qu'à l'agriculture
  • 05 - Produits pharmaceutiques, vétérinaires et hygièniques
  • 42 - Services scientifiques, technologiques et industriels, recherche et conception

Produits et services

Phytochemicals for use in the manufacturing of dietary supplements, nutritional products, pharmaceuticals and cosmetics; Chemical reagents for non-medical purposes; Chemical test kits for analytical measurement of raw material identity, potency and formulation consistency for laboratory or research use; Chemicals for use in industry and science; Chemicals for use in the biochemical and chemical industry; Assays for research purposes Dietary and nutritional supplements Innovation consulting services, namely, advising others in the areas of product development; Product development consulting in the field of dietary supplements, nutritional products, pharmaceuticals and cosmetics; Scientific consulting and research services relating to foods and dietary supplements; Chemical, biochemical, biological and bacteriological research and analysis; Consulting in the field of product development in the field of chemicals; Development and establishment of testing specifications and procedures in the field of chemicals; Development and test of chemical production methods; Development of voluntary standards for chemicals; Executing of chemical analyses; Industrial research in the field of chemicals; Pharmaceutical research and development; Product research and development; Research and development and consultation related thereto in the field of chemicals; Testing of raw materials

78.

METHOD FOR INDUCING UDP-GLUCURONOSYLTRANSFERASE ACTIVITY USING PTEROSTILBENE

      
Numéro d'application US2012064993
Numéro de publication 2013/169291
Statut Délivré - en vigueur
Date de dépôt 2012-11-14
Date de publication 2013-11-14
Propriétaire
  • CHROMADEX INC. (USA)
  • THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (USA)
Inventeur(s)
  • Bartos, Jeremy
  • Dellinger, Ryan

Abrégé

A method is provided for treating an individual for a cellular proliferative disorder, including administering to the individual in need of such treatment a therapeutically effective amount of the compound pterostilbene wherein UDP-glucuronosyltransferase (UGT) activity is increased. In an embodiment, 12-HETE levels can be reduced by administration of pterostilbene.

Classes IPC  ?

79.

PTEROSTILBENE AND CURCUMIN COMBINATION FOR TREATMENT OF OXIDATIVE STRESS AND INFLAMMATION

      
Numéro d'application US2013039105
Numéro de publication 2013/166177
Statut Délivré - en vigueur
Date de dépôt 2013-05-01
Date de publication 2013-11-07
Propriétaire CHROMADEX INC. (USA)
Inventeur(s) Bartos, Jeremy

Abrégé

A pharmaceutical composition is provided comprising a therapeutically effective amount of pterostilbene, a therapeutically effective amount of curcumin, and a pharmaceutically acceptable carrier. The embodiments of the pharmaceutical compositions can have lipid lowering properties, or alternatively can have properties that can treat oxidative stress, by decreasing inflammation or inflammatory processes contributing to digestive disorders or cancer. A method of treating an individual for an inflammatory disorder is provided, comprising administering to the individual in need of such treatment a pharmaceutical composition including a therapeutically effective amount of pterostilbene, a therapeutically effective amount of a curcumin, and a pharmaceutically acceptable carrier. The combination containing pterostilbene and curcumin is effective for treatment or prevention of oxidative stress, treatment of digestive disorders including inflammatory bowel disease, and/or to reduce or inhibit inflammation, in both animals and in humans.

Classes IPC  ?

  • A61K 31/09 - Éthers ou acétals ayant une liaison éther à un carbone cyclique d'un noyau aromatique ayant plusieurs liaisons éther
  • A61K 31/12 - Cétones

80.

PTEROSTILBENE AND PVP GRAPE JUICE EXTRACT COMBINATION FOR TREATMENT OF METABOLIC, VASCULAR, AND NEURODEGENERATIVE DISORDERS

      
Numéro d'application US2012069485
Numéro de publication 2013/090557
Statut Délivré - en vigueur
Date de dépôt 2012-12-13
Date de publication 2013-06-20
Propriétaire
  • CHROMADEX INC. (USA)
  • CLIFFSTAR LLC (USA)
Inventeur(s)
  • Bartos, Jeremy
  • Lynch, Douglas

Abrégé

A pharmaceutical composition is provided comprising a therapeutically effective amount of pterostilbene, a therapeutically effective amount of a polyphenolic-PVP extract of grape juice, and a pharmaceutically acceptable carrier. The embodiments of the pharmaceutical compositions can have lipid lowering properties, or alternatively can have properties that can treat oxidative stress, by decreasing inflammation or inflammatory processes contributing to neurodegenerative diseases. A method of lowering lipid levels in an individual is also provided, comprising administering to the individual in need of such treatment a pharmaceutical composition including a therapeutically effective amount of pterostilbene, a therapeutically effective amount of a polyphenolic-PVP extract of grape juice, and a pharmaceutically acceptable carrier, wherein lipid levels are decreased.

Classes IPC  ?

  • A61K 31/05 - Phénols
  • A61K 36/87 - Vitaceae ou Ampelidaceae (famille de la vigne ou du raisin), p. ex. raisin, vitis rotumdifolia ou vigne vierge

81.

NIAGEN

      
Numéro de série 85932490
Statut Enregistrée
Date de dépôt 2013-05-15
Date d'enregistrement 2014-09-16
Propriétaire ChromaDex Inc. ()
Classes de Nice  ?
  • 01 - Produits chimiques destinés à l'industrie, aux sciences ainsi qu'à l'agriculture
  • 05 - Produits pharmaceutiques, vétérinaires et hygièniques

Produits et services

Phytochemicals for use in the manufacturing of dietary supplements, nutritional products [, pharmaceuticals and cosmetics ] Dietary and nutritional supplements

82.

PTEROSTILBENE AND STATIN COMBINATION FOR TREATMENT OF METABOLIC DISEASE, CARDIOVASCULAR DISEASE, AND INFLAMMATION

      
Numéro d'application US2012055784
Numéro de publication 2013/040574
Statut Délivré - en vigueur
Date de dépôt 2012-09-17
Date de publication 2013-03-21
Propriétaire CHROMADEX INC. (USA)
Inventeur(s) Bartos, Jeremy

Abrégé

A pharmaceutical composition is provided comprising a therapeutically effective amount of pterostilbene, a therapeutically effective amount of a statin compound, and a pharmaceutically acceptable carrier. The embodiments of the pharmaceutical compositions can have lipid lowering properties, or alternatively can have properties that can treat oxidative stress, by decreasing inflammation or inflammatory processes contributing to neurodegenerative diseases. A method of lowering lipid levels in an individual is also provided, comprising administering to the individual in need of such treatment a pharmaceutical composition including a therapeutically effective amount of pterostilbene, a therapeutically effective amount of a statin compound, and a pharmaceutically acceptable carrier, wherein lipid levels are decreased.

Classes IPC  ?

  • A61K 38/00 - Préparations médicinales contenant des peptides

83.

PURENERGY

      
Numéro de série 85857505
Statut Enregistrée
Date de dépôt 2013-02-22
Date d'enregistrement 2014-04-08
Propriétaire ChromaDex Inc. ()
Classes de Nice  ? 01 - Produits chimiques destinés à l'industrie, aux sciences ainsi qu'à l'agriculture

Produits et services

Phytochemicals for use in the manufacturing of dietary supplements, nutritional products, * and * pharmaceuticals [ and cosmetics ]

84.

PTEROGOLD

      
Numéro de série 85502196
Statut En instance
Date de dépôt 2011-12-22
Propriétaire ChromaDex Inc. ()
Classes de Nice  ? 01 - Produits chimiques destinés à l'industrie, aux sciences ainsi qu'à l'agriculture

Produits et services

Phytochemicals for use in the manufacturing of dietary supplements, nutritional products, pharmaceuticals and cosmetics

85.

CHROMADEX

      
Numéro d'application 1075641
Statut Enregistrée
Date de dépôt 2011-03-24
Date d'enregistrement 2011-03-24
Propriétaire ChromaDex, Inc. (USA)
Classes de Nice  ?
  • 01 - Produits chimiques destinés à l'industrie, aux sciences ainsi qu'à l'agriculture
  • 42 - Services scientifiques, technologiques et industriels, recherche et conception

Produits et services

Chemical reagents for non-medical purposes; chemical test kits for analytical measurement of raw material identity, potency and formulation consistency for laboratory or research use; chemicals for use in industry and science; chemicals for use in the biochemical and chemical industry; assays for research purposes. Chemical, biochemical, biological and bacteriological research and analysis; consulting in the field of product development in the field of chemicals; development and establishment of testing specifications and procedures in the field of chemicals; development and test of chemical production methods; development of voluntary standards for chemicals; executing of chemical analyses; industrial research in the field of chemicals; pharmaceutical research and development; Product research and development; Research and development and consultation related thereto in the field of chemicals; testing of raw materials.

86.

PTEROPURE

      
Numéro de série 77939875
Statut Enregistrée
Date de dépôt 2010-02-19
Date d'enregistrement 2011-03-15
Propriétaire ChromaDex Inc. ()
Classes de Nice  ? 01 - Produits chimiques destinés à l'industrie, aux sciences ainsi qu'à l'agriculture

Produits et services

Phytochemicals for use in the manufacturing of dietary supplements and nutritional products

87.

CHROMADEX

      
Numéro de série 77939870
Statut Enregistrée
Date de dépôt 2010-02-19
Date d'enregistrement 2011-07-19
Propriétaire ChromaDex Inc. ()
Classes de Nice  ?
  • 01 - Produits chimiques destinés à l'industrie, aux sciences ainsi qu'à l'agriculture
  • 42 - Services scientifiques, technologiques et industriels, recherche et conception

Produits et services

[ Chemical reagents for non-medical purposes; ] Chemical test kits for analytical measurement of raw material identity, potency and formulation consistency for laboratory or research use; Chemicals for use in industry and science; Chemicals for use in the biochemical and chemical industry; Assays for research purposes Chemical, biochemical, biological and bacteriological research and analysis; Consulting in the field of product development in the field of chemicals; Development and establishment of testing specifications and procedures in the field of chemicals; Development and test of chemical production methods; Development of voluntary standards for chemicals; Executing of chemical analyses; [ Industrial research in the field of chemicals; ] Pharmaceutical research and development; Product research and development; Research and development and consultation related thereto in the field of chemicals; Testing of raw materials